AB 2276: Childhood lead poisoning: screening and prevention.
- Session Year: 2019-2020
- House: Assembly
- Latest Version Date: 2020-09-28
|
Date
|
Status
|
|---|---|
| Sep 28, 2020 | Chaptered by Secretary of State - Chapter 216, Statutes of 2020. |
| Sep 28, 2020 | Approved by the Governor. |
| Sep 10, 2020 | Enrolled and presented to the Governor at 2:30 p.m. |
| Aug 30, 2020 | Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 75. Noes 0. Page 5363.). |
| Aug 29, 2020 | In Assembly. Concurrence in Senate amendments pending. |
| Aug 29, 2020 | Read third time. Passed. Ordered to the Assembly. (Ayes 38. Noes 0. Page 4436.). |
| Aug 26, 2020 | Read second time. Ordered to third reading. |
| Aug 25, 2020 | Read third time and amended. Ordered to second reading. |
| Aug 24, 2020 | Read second time. Ordered to third reading. |
| Aug 20, 2020 | From committee: Amend, and do pass as amended. (Ayes 7. Noes 0.) (August 20). |
| Aug 13, 2020 | In committee: Referred to APPR. suspense file. |
| Aug 5, 2020 | Read second time and amended. Re-referred to Com. on APPR. |
| Aug 4, 2020 | From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 8. Noes 0.) (August 1). |
| Jul 27, 2020 | From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH. |
| Jul 22, 2020 | From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH. |
| Jul 1, 2020 | Referred to Com. on HEALTH. |
| Jun 11, 2020 | In Senate. Read first time. To Com. on RLS. for assignment. |
| Jun 10, 2020 | Read third time. Passed. Ordered to the Senate. (Ayes 78. Noes 0. Page 4758.) |
| Jun 4, 2020 | Coauthors revised. |
| Jun 3, 2020 | From committee: Do pass. (Ayes 18. Noes 0.) (June 3). |
| Jun 2, 2020 | In committee: Set, first hearing. Referred to APPR. suspense file. |
| May 19, 2020 | From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 15. Noes 0.) (May 18). Re-referred to Com. on APPR. |
| May 13, 2020 | Re-referred to Com. on HEALTH. |
| May 12, 2020 | From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. |
| Feb 24, 2020 | Referred to Com. on HEALTH. |
| Feb 15, 2020 | From printer. May be heard in committee March 16. |
| Feb 14, 2020 | Read first time. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Aug 30, 2020 | AB 2276 Reyes Concurrence in Senate Amendments | Assembly Floor |
Passed |
|
| Aug 29, 2020 | Assembly 3rd Reading AB2276 Reyes et al. By Leyva | Senate Floor |
Passed |
|
| Aug 20, 2020 | Do pass as amended | Senate Standing Committee on Appropriations |
Passed |
|
| Aug 13, 2020 | Placed on suspense file | Senate Standing Committee on Appropriations |
Passed |
|
| Aug 1, 2020 | Do pass as amended, but first amend, and re-refer to the Committee on [Appropriations] | Senate Standing Committee on Health |
Passed |
|
| Jun 10, 2020 | AB 2276 Reyes Assembly Third Reading | Assembly Floor |
Passed |
|
| Jun 3, 2020 | Do pass. | Assembly Standing Committee on Appropriations |
Passed |
|
| May 18, 2020 | Do pass and be re-referred to the Committee on [Appropriations] with recommendation: To Consent Calendar | Assembly Standing Committee on Health |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
CONCURRENCE IN SENATE AMENDMENTS
CSA1 Bill Id:AB 2276
Author:(Reyes, et al.)
As Amended Ver:August 25, 2020
Majority vote
SUMMARY:
Requires a contract between Department of Health Care Services (DHCS) a Medi-Cal managed care (MCMC) plan to require the plan to identify, on a quarterly basis, every enrollee who is a child without a record of completing the blood lead screening tests required pursuant to state regulation, and to remind the contracting network health care provider responsible for performing the periodic health assessment of the child enrollee pursuant to state regulation of the requirement to perform required blood lead screening tests for that child, and the requirement to provide oral or written anticipatory guidance to a parent or guardian of the child, including at a minimum, the information that children may be harmed by exposure to lead. Requires DHCS to develop and implement procedures, and requires, as part of these procedures, DHCS to require a MCMC plan to maintain a record of all child enrollees six years of age or younger who have missed a required blood lead screening and identify the age at which the required blood lead screenings were missed, including which children are without any record of a completed blood lead screening at each age, and provide that record to DHCS annually and upon request for auditing and compliance purposes. Requires the MCMC plan, if the child enrollee, or the child enrollee's parent, guardian, or authorized representative refuses a required blood lead screening test, to ensure a statement of voluntary refusal is signed by the child enrollee, if an emancipated minor, or by the child enrollee's parent, guardian, or authorized representative, and is documented in the child enrollee's medical record.
The Senate Amendments:
- Delete the Medi-Cal blood lead screening goals in the Assembly-approved version of this bill.
- Delete the requirement in the Assembly-approved version of this bill that MCMC plans establish a monitoring system that ensures each child receives required blood lead screening tests, and that plans report data to DHCS on the number of children at one and two years of age who have received a blood lead screening test and associated case management services.
- Delete the requirement in the Assembly-approved version of this bill that, at the time that a child under six years of age becomes a beneficiary under the Medi-Cal program, and annually thereafter, up to six years of age, inform the child's parent, parents, guardian, or other person charged with their support and maintenance about the risks and effects of lead exposure, the requirement for a child to receive blood lead screening tests at age appropriate intervals, and the recommendation that a child receive a blood lead screening test if they are at risk of lead exposure.
- Delete the requirement in the Assembly-approved version of this bill that the MCMC plan notify the child's health care provider when the child misses a required blood lead screening test within 30 days of the missed test.
- Require the California Department of Public Health (DPH), to ensure that the Childhood Lead Poisoning Prevention Program (CLPPP) funds are allocated to each local agency equitably and commensurate with the level of services needed to provide to children with elevated blood levels, to update its formula for allocating funds to a local agency that contracts with DHP to administer the CLPPP, and to revise funding allocations before each contract cycle.
- Require DPH, when revising the allocation formula, to take into account the most recent data for the number of children with elevated blood lead levels in each jurisdiction.
- Define "elevated blood levels" to mean a blood lead level that is no higher than the blood lead reference value as specified in the most recent guidelines issued by the federal Centers for Disease Control and Prevention.
- Require the DPH regulations establishing a standard of care for evaluation of risk for lead poisoning to include the additional risk factors, including:
- Other potential risk factors for lead exposure, and known sources of lead contamination.
- A child's residency in or visit to a foreign country.
- A child's residency in a high-risk ZIP Code.
- A child who has a sibling or playmate with lead poisoning.
- The likelihood of a child placing nonfood items in the mouth.
- A child's proximity to current or former lead-producing facilities.
- The likelihood of a child using food, medicine, or dishes from other countries.
COMMENTS:
In January 2020, the California State Auditor (CSA) released an audit entitled "Childhood Lead Levels – Millions of Children in Medi-Cal Have Not Received Required Testing for Lead Poisoning." The CSA audit is critical of DHCS and DPH, stating that millions of children who should have been tested for elevated lead levels have not received all of the tests they should have because DHCS and DPH have failed to adequately accomplish the duties with which they have been entrusted. Related to what MCMC plans could do to improve lead screening, the CSA stated DHCS could:
- Require MCMC plans to identify children who have not received lead tests and remind their health care providers of the need to provide the tests—a method other states have successfully used to increase testing rates;
- Prioritize its effort to adopt a performance standard for lead tests and ensure that this standard is specifically designed to monitor its success in meeting the State's requirements for the lead testing of one‑ and two‑year‑old children; and,
- Incorporate into its contracts with MCMC plans a requirement that the plans identify each month all children without records of required lead tests and remind the responsible health care providers of the need to test those children.
The Senate amendments merge the contents of AB 2277 (Salas, et al.) of the current legislative session and AB 2279 (C. Garcia, et. al) of the current legislative session into this bill, with DHCS-proposed changes to the merged provisions.
According to the Author:
Protecting the state's most vulnerable must be a top priority for the Legislature. Studies have shown that lead exposure disproportionately impacts low income communities, and that the damage can cause cognitive disabilities and other forms of irreparable harm. This bill ensures that vulnerable children, such as those on Medi-Cal, are receiving blood lead tests by creating the necessary accountability mechanisms to ensure compliance and proper tracking of existing blood lead test mandates; a need indicated by the State Auditor.
Arguments in Support:
This bill is jointly sponsored by the Environmental Working Group and the Coalition of California Welfare Rights and Organizations, which write that lead is a severe neurotoxin that even in small doses can lower a child's IQ and cause behavior and learning disorders. All children can be exposed to lead, but DPH states that the vast majority – 88% - of California's lead-poisoned kids are enrolled in Medi-Cal. Low-income children are more apt to be lead-poisoned because they are more likely to live in older housing with lead paint, and be malnourished, which causes them to absorb lead faster. If not stopped, a child's ongoing exposure to lead will continue to harm their nervous system, and cause damage that can last a lifetime. Because lead exposure happens silently, and disproportionately affects low income kids, state and federal regulations require all Medi-Cal toddlers to receive blood lead tests when they are one and two years old. Unfortunately, many of these children are not tested as required. A recent state audit of state data found that an estimated 70% of the state's 12 and 24-month old children who are enrolled in Medi-Cal do not receive blood lead screenings each year in accordance with federal and state regulations. This finding supports several other analyses, including one published in the peer-reviewed journal Pediatrics. This analysis found that more than 63% of California's children with elevated blood lead levels above 10 mcg/dL are not identified. California must and should identify as many lead-exposed children as the law requires. At the minimum, DHCS should ensure that the established lead-testing requirement for Medi-Cal recipient children is met, and DHCS should develop a case management system that will allow the state to track these childrens' blood lead tests. In addition, parents of Medi-Cal children should be informed about the federal childhood blood lead screening requirements, as well as the risks associated with childhood lead exposure. This bill addresses these needs and will bring California many steps closer to ensuring that our most vulnerable children receive protective lead screening services and information.
Arguments in Opposition:
The Department of Finance writes that it is opposed to this bill because it would result in significant General Fund costs not included in the 2020 Budget Act and is duplicative of efforts currently underway by DHCS and DPH as detailed in the report titled California's Progress in Preventing and Managing Childhood Lead Exposure published June 2020.
FISCAL COMMENTS:
According to the Senate Appropriations Committee:
- Staff notes unknown, significant ongoing administrative costs (high hundreds of thousands to low millions General Fund/federal fund) for DHCS for additional resources and ongoing workload to monitor health plan compliance with contracts, including its communication to families about blood lead screening tests, data reporting, and meeting specified state goals.
- Staff notes indeterminate, significant ongoing administrative costs (low to mid- hundreds of thousands, General Fund) for DPH in staff resources to conduct a review of existing CLPPP funding levels and revise allocation formulas, as needed. Costs to promulgate additional regulations may be short-term.
VOTES:
ASM HEALTH: 15-0-0
YES: Wood, Mayes, Aguiar-Curry, Bigelow, Bonta, Burke, Carrillo, Flora, Limón, McCarty, Nazarian, Ramos, Rodriguez, Santiago, Waldron
ASM APPROPRIATIONS: 18-0-0
YES: Gonzalez, Bigelow, Bauer-Kahan, Bloom, Bonta, Calderon, Carrillo, Chau, Megan Dahle, Diep, Eggman, Fong, Gabriel, Eduardo Garcia, Petrie-Norris, McCarty, Robert Rivas, Voepel
ASSEMBLY FLOOR: 78-0-1
YES: Aguiar-Curry, Arambula, Bauer-Kahan, Berman, Bigelow, Bloom, Boerner Horvath, Bonta, Brough, Burke, Calderon, Carrillo, Cervantes, Chau, Chen, Chiu, Choi, Chu, Cooley, Cooper, Cunningham, Megan Dahle, Daly, Diep, Eggman, Flora, Fong, Frazier, Friedman, Gabriel, Gallagher, Cristina Garcia, Eduardo Garcia, Gipson, Gloria, Gonzalez, Gray, Grayson, Holden, Irwin, Jones-Sawyer, Kalra, Kamlager, Kiley, Lackey, Levine, Limón, Low, Maienschein, Mathis, Mayes, McCarty, Medina, Mullin, Muratsuchi, Nazarian, O'Donnell, Obernolte, Patterson, Petrie-Norris, Quirk-Silva, Ramos, Reyes, Luz Rivas, Robert Rivas, Rodriguez, Blanca Rubio, Salas, Santiago, Smith, Mark Stone, Ting, Voepel, Waldron, Weber, Wicks, Wood, Rendon
ABS, ABST OR NV: Quirk
SENATE FLOOR: 38-0-2
YES: Allen, Archuleta, Atkins, Bates, Beall, Borgeas, Bradford, Caballero, Chang, Dahle, Dodd, Durazo, Galgiani, Glazer, Lena Gonzalez, Grove, Hertzberg, Hill, Hueso, Hurtado, Jackson, Leyva, McGuire, Melendez, Mitchell, Monning, Moorlach, Morrell, Nielsen, Pan, Portantino, Roth, Rubio, Skinner, Umberg, Wieckowski, Wiener, Wilk
ABS, ABST OR NV: Jones, Stern
UPDATED:
VERSION: August 25, 2020
CONSULTANT: Scott Bain / HEALTH / (916) 319-2097 FN: 0003325
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | AB 2276 |
THIRD READING
Bill No: AB 2276
Author: Reyes (D), Cristina Garcia (D), Quirk (D) and Salas (D), et al.
Amended: 8/25/20 in Senate
Vote: 21
SENATE HEALTH COMMITTEE: 8-0, 8/1/20
AYES: Pan, Lena Gonzalez, Grove, Hurtado, Leyva, Mitchell, Monning, Rubio
NO VOTE RECORDED: Melendez
SENATE APPROPRIATIONS COMMITTEE: 7-0, 8/20/20
AYES: Portantino, Bates, Bradford, Hill, Jones, Leyva, Wieckowski
ASSEMBLY FLOOR: 78-0, 6/10/20 - See last page for vote
SUBJECT: Childhood lead poisoning: screening and prevention
SOURCE: California Coalition of Welfare Rights Organizations
Environmental Working Group
Western Center on Law and Poverty
DIGEST:
This bill (1) creates additional risk factors to be considered by health care providers evaluating children at risk of lead poisoning, and requires the Department of Public Health (DPH) to update its formula for allocating funds to local Childhood Lead Poisoning Prevention Programs; (2) requires Medi-Cal managed care plans (MCPs) to identify and provide a report to the Department of Health Care Services (DHCS) on all child enrollees six years of age and younger who have a missed a required blood lead screening test and the age at which the required test was missed; and, (3) requires Medi-Cal MCP to remind health care providers of children on Medi-Cal of the blood lead screening test and other requirements.
Senate Floor Amendments of 8/25/20:
- Delete the requirements from the bill for:
- DPH to develop regulations on additional risk factors by January 1, 2021;
- The Early and Periodic Screening, Diagnostic and Treatment (EPSDT) benefit include specified goals for childhood blood lead screening, consistent with existing regulations;
- DHCS to ensure each child receives required blood lead screening tests, consistent with existing regulations;
- DHCS to annually post on its Medi-Cal dashboard a report detailing DHCS’ progress toward the goals specified for childhood blood lead screening under the EPSDT benefit required by this bill;
- Medi-Cal MCPs to establish a monitoring system for ensuring each child receives required blood lead screening tests;
- Medi-Cal MCPs, on a quarterly basis, to notify a child’s health care provider when the child misses a required blood lead screening;
- Medi-Cal MCPs to notify the parent, guardian, or other person charged with the support and maintenance of a child under the age of six, at the time the child becomes a Medi-Cal beneficiary and annually thereafter, as specified.
- Recast requirements on Medi-Cal MCPs as requirements on the contract between DHCS and a Medi-Cal MCP.
- Require contracts between DHCS and a Medi-Cal MCP to require Medi-Cal MCPs, on a quarterly basis, to remind contracting network providers responsible for periodic health assessment of child of the requirement to perform required blood lead screening tests and the requirement to provide anticipatory guidance on lead exposure to the parent or guardian of the child.
- Require DHCS to require Medi-Cal MCPs to provide DHCS, annually and upon request for auditing and compliance purposes, a record of all child enrollees six years of age and younger who have a missed a required blood lead screening test and the age at which the required test was missed.
- Require Medi-Cal MCP to ensure a child or child’s parent or guardian signs a statement of voluntary refusal if a required blood lead screening test is refused. Requires the Medi-Cal MCP to document if the refusing party declines to sign the statement of voluntary refusal. Requires documented unsuccessful attempts to provide blood lead screening tests as evidence of the Medi-Cal MCP meeting the requirements of this bill.
- Require DHCS to develop and implement procedures to ensure Medi-Cal MCPs comply with the provisions of this bill, including authorizing DHCS to impose sanctions, consistent with existing law.
ANALYSIS:
Existing law:
- Establishes the Childhood Lead Poisoning Prevention Act of 1991. [HSC §105275]
- Requires DPH to adopt regulations establishing a standard of care, at least as stringent as the most recent federal Centers for Disease Control and Prevention (CDC) screening guidelines, whereby all children are evaluated for risk of lead poisoning by health care providers during each child’s periodic health assessment. [HSC §105285]
- Requires the regulations to include the determination of risk factors for whether a child is “at risk,” and consider the most significant environmental risk factors, including, but not limited to, all of the following:
- A child’s time spent in a home, school, or building built before 1978;
- A child’s proximity to a former lead or steel smelter or an industrial facility that historically emitted or currently emits lead;
- A child’s proximity to a freeway or heavily traveled roadway; and,
- Other potential risk factors for lead exposure, and known sources of lead contamination. [HSC §105285]
- Requires DPH to ensure appropriate case management when a child is identified with lead poisoning, and permits DPH to contract with any public or private entity, including local agencies, to conduct the case management. [HSC §105290]
- Requires DPH to collect and analyze all information necessary to effectively monitor appropriate case management efforts. Requires DPH to prepare a biennial report describing the effectiveness of appropriate case management efforts, and make it available to local health departments and the general public. [HSC §105290]
- Gives DPH broad regulatory authority to fully implement and effectuate the Child Lead Poisoning Prevention Program (CLPPP) including, but not limited to, the following:
- The development of protocols to be utilized in screening and the procedures for changing those protocols when more accurate or efficient technologies become available;
- The designation of laboratories which are qualified to analyze whole blood specimens for concentrations of lead and the monitoring of those laboratories for accuracy;
- The development of reporting procedures by laboratories;
- The reimbursement for state-sponsored services related to screening and appropriate case management;
- The establishment of lower concentrations of lead in whole blood than those specified by the United States Centers for Disease Control (CDC) for the purpose of determining the existence of lead poisoning;
- The establishment of lower acceptable levels of the concentration of lead in whole blood than those specified by the CDC for the purpose of determining the need to provide appropriate case management for lead poisoning;
- The development of appropriate case management protocols;
- The notification to the child’s parent or guardian of the results of blood lead testing and environmental assessment; and,
- The establishment of a periodicity schedule for evaluation for childhood lead poisoning. [HSC §105300]
- Establishes the Medi-Cal program, which is administered by the Department of Health Care Services (DHCS) and under which qualified low-income individuals receive health care services. [WIC §14000, et seq.]
- Establishes a schedule of benefits in the Medi-Cal program, including EPSDT program that requires testing and treatment for elevated blood lead levels for children at 12 month and 24 months of age, consistent with the requirements of the federal Medicaid program. [WIC §14132]
This bill:
- Adds to the determination of risk factors to be considered by health care providers evaluating children at risk of lead poisoning, the following:
- A child’s residency in or visit to a foreign country;
- A child’s residency in a high-risk ZIP Code;
- A child who has a sibling or playmate with lead poisoning;
- The likelihood of a child placing nonfood items in the mouth;
- A child’s proximity to current or former lead-producing facilities; and,
- The likelihood of a child using food, medicine, or dishes from other countries.
- Requires DPH to update its formula for allocating funds to any local agency that contracts with DPH to administer CLPPP to ensure that funds are allocated equitably and commensurate with the level of services needed to provide to children with elevated blood levels, and to revise funding allocations before each contract cycle. Requires DPH to take into account the most recent data for the number of children with elevated blood lead levels in each jurisdiction when revising the allocation formula.
- Defines “elevated blood levels” as a blood lead level that is no higher than the blood lead reference value as specified in the most recent guidelines issued by CDC.
- Requires the contract between DHCS and a Medi-Cal MCP to require the Medi-Cal MCP to do both of the following :
- Identify, on a quarterly basis, every enrollee who is a child without a record of completing the blood lead screening tests required by existing law; and,
- On a quarterly basis, remind contracting network providers responsible for periodic health assessment of child of the requirement to perform required blood lead screening tests and the requirement to provide anticipatory guidance on lead exposure to the parent or guardian of the child.
- Requires DHCS to require Medi-Cal MCPs to provide DHCS, annually and upon request for auditing and compliance purposes, a record of all child enrollees six years of age and younger who have a missed a required blood lead screening test and the age at which the required test was missed.
- Requires Medi-Cal MCP to ensure a child or child’s parent or guardian signs a statement of voluntary refusal if a required blood lead screening test is refused. Requires the Medi-Cal MCP to document if the refusing party declines to sign the statement of voluntary refusal. Requires documented unsuccessful attempts to provide blood lead screening tests as evidence of the Medi-Cal MCP meeting the requirements of this bill.
- Requires DHCS to develop and implement procedures to ensure Medi-Cal MCPs comply with the provisions of this bill, including authorizing DHCS to impose sanctions, consistent with existing law.
Comments
- Author’s statement. According to the author, protecting the state’s most vulnerable must be a top priority for the Legislature. Studies have shown that lead exposure disproportionately impacts low income communities, and that the damage can cause cognitive disabilities and other forms of irreparable harm. A report released by the State Auditor found that more than 1.4 million one and two year old children did not receive any of the required tests and noted California ranks 31st in the nation for providing lead tests to one and two year olds. The failure to ensure that millions of children enrolled in Medi-Cal receive the required lead testing puts the health and safety of our most vulnerable populations at risk for lead poisoning. This bill ensures that vulnerable children, such as those on Medi-Cal, are receiving blood lead tests by creating the necessary accountability mechanisms to ensure compliance and proper tracking of existing blood lead test mandates. This bill also requires DPH to update its Local Prevention Program Funding Allocation Methodology to guarantee a more equitable distribution of funds and adds several known risk factors for lead poisoning to ensure that our children receive the proper care under the CLPPP.
- State Auditor report. In January 2020, California’s State Auditor completed its audit report of DHCS and DPH, which focused on both the administration of lead tests to children in Medi-Cal and the activities of CLPPP. The audit determined that millions of children in Medi-Cal are not receiving the lead tests they should be receiving, and DPH is not prioritizing the prevention of lead poisoning. The audit found that from fiscal years 2009–10 through 2017–18, more than 1.4 million of the 2.9 million one- and two-year-old children enrolled in Medi-Cal did not receive any of the required tests, and another 740,000 children missed one of the two required tests. As a result, the rate of eligible children receiving all of the tests that they should have was less than 27%. Without these tests, health care providers do not know whether these children are suffering from elevated lead levels and need treatment. Despite low lead testing rates, DHCS has only recently begun developing an incentive program to increase testing and a performance standard for measuring the extent to which managed care plans are providing the tests. The audit also found that DPH, and the CLPPP, does not focus on proactive abatement of lead hazards to prevent future poisoning. Finally, DPH has failed to meet several legislative requirements, including a mandate to update the factors that health care providers must use to determine whether a child is at risk of lead exposure, which help them identify children who need testing.
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: No
According to the Senate Appropriations Committee:
- DHCS. Staff notes unknown, significant ongoing administrative costs (high hundreds of thousands to low millions General Fund [GF]/federal fund) for additional resources and ongoing workload to monitor health plan compliance with contracts, including its communication to families about blood lead screening tests, data reporting, and meeting specified state goals.
- DPH. Staff notes indeterminate, significant ongoing administrative costs (low to mid- hundreds of thousands, GF) in staff resources to conduct a review of existing CLPPP funding levels and revise allocation formulas, as needed. Costs to promulgate additional regulations may be short-term.
SUPPORT: (Verified 8/21/20)
Environmental Working Group (co-source)
California Coalition of Welfare Rights Organizations (co-source)
Western Center on Law and Poverty (co-source)
American Academy of Pediatrics, California
Asian Resources, Inc.
Association of Regional Center Agencies
California League of Conservation Voters
California Pan-Ethnic Health Network
California Society of Health-System Pharmacists
Californiahealth+ Advocates
CalPIRG
Center for Environmental Health
Children Now
Children’s Defense Fund-California
City of Alameda
Clean Water Action
Community Clinic Association of Los Angeles County
Environmental Health Coalition
Friends Committee on Legislation of California
Healthy Black Families, Inc.
Maternal and Child Health Access
National Association of Social Workers, California Chapter
National Health Law Program
Natural Resources Defense Council
Sierra Club California
Smart Oakland
OPPOSITION: (Verified 8/21/20)
Department of Finance
ARGUMENTS IN SUPPORT: This is bill sponsored by Environmental Working Group, California Coalition of Welfare Rights Organizations, and Western Center on Law and Poverty, which write in a joint letter that all children can be exposed to lead, but, according to CDPH, the vast majority of California’s lead-poisoned kids are enrolled in Medi-Cal. Low-income kids are more apt to be lead-poisoned because they are more likely to live in older housing with lead paint, and be malnourished, which causes them to absorb lead faster. If not stopped, a child’s ongoing exposure to lead will continue to harm their nervous system, and cause damage that can last a lifetime. California must and should identify as many lead-exposed children as the law requires. At the minimum, DHCS should ensure that the established lead-testing requirement for Medi-Cal recipient children is met, and DHCS should develop a system to track these children’s’ blood lead tests and follow-up services. In addition, parents and healthcare providers of Medi-Cal children should be informed when a child has missed a required test, and DPH testing requirements as well as funding distribution formulas for local CLPP programs should be updated.
ARGUMENTS IN OPPOSITION: Department of Finance is opposed to this bill because it would result in significant GF costs not included in the 2020 Budget Act and is duplicative of efforts currently underway by DHCS and DPH described in the state auditor’s report.
ASSEMBLY FLOOR: 78-0, 6/10/20
AYES: Aguiar-Curry, Arambula, Bauer-Kahan, Berman, Bigelow, Bloom, Boerner Horvath, Bonta, Brough, Burke, Calderon, Carrillo, Cervantes, Chau, Chen, Chiu, Choi, Chu, Cooley, Cooper, Cunningham, Megan Dahle, Daly, Diep, Eggman, Flora, Fong, Frazier, Friedman, Gabriel, Gallagher, Cristina Garcia, Eduardo Garcia, Gipson, Gloria, Gonzalez, Gray, Grayson, Holden, Irwin, Jones-Sawyer, Kalra, Kamlager, Kiley, Lackey, Levine, Limón, Low, Maienschein, Mathis, Mayes, McCarty, Medina, Mullin, Muratsuchi, Nazarian, Obernolte, O'Donnell, Patterson, Petrie-Norris, Quirk-Silva, Ramos, Reyes, Luz Rivas, Robert Rivas, Rodriguez, Blanca Rubio, Salas, Santiago, Smith, Mark Stone, Ting, Voepel, Waldron, Weber, Wicks, Wood, Rendon
NO VOTE RECORDED: Quirk
Prepared by: Kimberly Chen / HEALTH / (916) 651-4111
8/26/20 14:47:05
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | AB 2276 |
THIRD READING
Bill No: AB 2276
Author: Reyes (D), Cristina Garcia (D), Quirk (D) and Salas (D), et al.
Amended: 8/20/20 in Senate
Vote: 21
SENATE HEALTH COMMITTEE: 8-0, 8/1/20
AYES: Pan, Lena Gonzalez, Grove, Hurtado, Leyva, Mitchell, Monning, Rubio
NO VOTE RECORDED: Melendez
SENATE APPROPRIATIONS COMMITTEE: 7-0, 8/20/20
AYES: Portantino, Bates, Bradford, Hill, Jones, Leyva, Wieckowski
ASSEMBLY FLOOR: 78-0, 6/10/20 - See last page for vote
SUBJECT: Childhood lead poisoning: screening and prevention
SOURCE: California Coalition of Welfare Rights Organizations
Environmental Working Group
Western Center on Law and Poverty
DIGEST:
This bill (1) creates additional risk factors to be considered by health care providers evaluating children at risk of lead poisoning, and requires the Department of Public Health to update its formula for allocating funds to local Childhood Lead Poisoning Prevention Programs; (2) establishes blood lead screening tests goals for the Medi-Cal program; (3) requires the Department of Health Care Services to meet and report progress on meeting blood lead screening test goals; and (4) requires Medi-Cal managed care plans to notify the family and health care providers of children on Medi-Cal about blood lead screening requirements and whether children have missed required blood lead screening tests.
ANALYSIS:
Existing law:
- Establishes the Childhood Lead Poisoning Prevention Act of 1991. [HSC §105275]
- Requires the Department of Public Health (DPH) to adopt regulations establishing a standard of care, at least as stringent as the most recent federal Centers for Disease Control and Prevention (CDC) screening guidelines, whereby all children are evaluated for risk of lead poisoning by health care providers during each child’s periodic health assessment. [HSC §105285]
- Requires the regulations to include the determination of risk factors for whether a child is “at risk,” and consider the most significant environmental risk factors, including, but not limited to, all of the following:
- A child’s time spent in a home, school, or building built before 1978;
- A child’s proximity to a former lead or steel smelter or an industrial facility that historically emitted or currently emits lead;
- A child’s proximity to a freeway or heavily traveled roadway; and,
- Other potential risk factors for lead exposure, and known sources of lead contamination. [HSC §105285]
- Requires DPH to ensure appropriate case management when a child is identified with lead poisoning, and permits DPH to contract with any public or private entity, including local agencies, to conduct the case management. [HSC §105290]
- Requires DPH to collect and analyze all information necessary to effectively monitor appropriate case management efforts. Requires DPH to prepare a biennial report describing the effectiveness of appropriate case management efforts, and make it available to local health departments and the general public. [HSC §105290]
- Gives DPH broad regulatory authority to fully implement and effectuate the Child Lead Poisoning Prevention Program (CLPPP) including, but not limited to, the following:
- The development of protocols to be utilized in screening and the procedures for changing those protocols when more accurate or efficient technologies become available;
- The designation of laboratories which are qualified to analyze whole blood specimens for concentrations of lead and the monitoring of those laboratories for accuracy;
- The development of reporting procedures by laboratories;
- The reimbursement for state-sponsored services related to screening and appropriate case management;
- The establishment of lower concentrations of lead in whole blood than those specified by the United States Centers for Disease Control (CDC) for the purpose of determining the existence of lead poisoning;
- The establishment of lower acceptable levels of the concentration of lead in whole blood than those specified by the CDC for the purpose of determining the need to provide appropriate case management for lead poisoning;
- The development of appropriate case management protocols;
- The notification to the child’s parent or guardian of the results of blood lead testing and environmental assessment; and,
- The establishment of a periodicity schedule for evaluation for childhood lead poisoning. [HSC §105300]
- Establishes the Medi-Cal program, which is administered by the Department of Health Care Services (DHCS) and under which qualified low-income individuals receive health care services. [WIC §14000, et seq.]
- Establishes a schedule of benefits in the Medi-Cal program, including the Early and Periodic Screening, Diagnostic and Treatment (EPSDT) program that requires testing and treatment for elevated blood lead levels for children at 12 month and 24 months of age, consistent with the requirements of the federal Medicaid program. [WIC §14132]
This bill:
- Adds to the determination of risk factors to be considered by health care providers evaluating children at risk of lead poisoning, the following:
- A child’s residency in or visit to a foreign country;
- A child’s residency in a high-risk ZIP Code;
- A child who has a sibling or playmate with lead poisoning;
- The likelihood of a child placing nonfood items in the mouth;
- A child’s proximity to current or former lead-producing facilities; and,
- The likelihood of a child using food, medicine, or dishes from other countries.
- Requires regulations to be developed by January 1, 2021 in consultation with medical experts, environmental experts, appropriate professional organizations, the public, and others as determined by DPH.
- Requires DPH to update its formula for allocating funds to any local agency that contracts with DPH to administer CLPPP to ensure that funds are allocated equitably and commensurate with the level of services needed to provide to children with elevated blood levels, and to revise funding allocations before each contract cycle. Requires DPH to take into account the most recent data for the number of children with elevated blood lead levels in each jurisdiction when revising the allocation formula.
- Defines “elevated blood levels” as a blood lead level that is no higher than the blood lead reference value as specified in the most recent guidelines issued by CDC.
- Requires the EPSDT benefit for Medi-Cal to include the following goals:
- Every child at risk of lead exposure receives blood lead screening tests, consistent with existing law;
- Every child who is eligible for services under the Medi-Cal program receives blood lead screening tests at 12 and 24 months of age, consistent with existing regulations; and,
- Every child, between two and six years of age, who is eligible for services under the Medi-Cal program, and for whom there is no record of a previous blood lead screening test, receives at least one blood lead screening test pursuant to the most recent guidelines published by the CDC.
- Requires DHCS to annually post on its Medi-Cal dashboards on its website a report detailing DHCS’ progress toward the goals specified in 5) above. Requires the report to include the number of Medi-Cal beneficiaries in each county who have and have not received blood lead screening tests, identified by the following age groups:
- Newborn to one year of age, inclusive;
- One year and one day to two years of age, inclusive; and,
- Two years and one day to six years of age, inclusive.
- Requires DHCS to ensure the following for a Medi-Cal beneficiary who is a child, consistent with existing regulations:
- A child receives a blood lead screening test at 12 and 24 months of age; and,
- A child between two and six years of age, who does not have a record of a previous blood lead screening test, receives at least one blood lead screening.
- Requires a Medi-Cal managed care plan (MCP), in order to comply with blood lead screening test requirements, to do all of the following:
- Identify, on a quarterly basis, every beneficiary six years of age or younger that has missed a required blood lead screening and identify the age at which the required blood lead screenings were missed, including which children are without any record of a completed blood lead screening at each age;
- Notify the child’s health care provider when the child misses a required blood lead screening test. Requires the notification to be sent within 30 days of the missed test;
- Report data to DHCS on the number of children six years of age and young, by each age, who have received a blood lead screening test;
- Require its contracting health care providers who are responsible for performing a periodic health assessment of a child to test each child, consistent with state and federal law, regulations, and DHCS’s Blood Lead Test and Anticipatory Guidance guidelines;
- Notify its contracting health care providers of the requirement to perform periodic child health assessments and blood led tests;
- Notify the parent, guardian, or other person charged with the support and maintenance of a child under the age of six, at the time the child becomes a Medi-Cal beneficiary and annually thereafter, all of the following:
- The risks and effects of lead exposure;
- The requirement for a child to receive blood lead screening tests at age appropriate intervals;
- The recommendation that a child receive a blood lead screening test if they are at risk of lead exposure; and,
- A notification of a missed screening, if the child missed a required blood lead screening test. Requires the notification to be included in an annual notice to the family of a child who has not used preventive services in the course of the year; and,
- Notify the child’s parent, parents, guardian, or other person charged with the support and maintenance of that child when the child misses a required blood lead screening test at 12 and 24 months of age. Requires the notification to be included in an annual notification to each family of a child who has not used preventive services over the course of the year.
- Requires the contract between DHCS and a Medi-Cal MCP to include the requirements of 8) above.
Comments
- Author’s statement. According to the author, protecting the state’s most vulnerable must be a top priority for the Legislature. Studies have shown that lead exposure disproportionately impacts low income communities, and that the damage can cause cognitive disabilities and other forms of irreparable harm. A report released by the State Auditor found that more than 1.4 million one and two year old children did not receive any of the required tests and noted California ranks 31st in the nation for providing lead tests to one and two year olds. The failure to ensure that millions of children enrolled in Medi-Cal receive the required lead testing puts the health and safety of our most vulnerable populations at risk for lead poisoning. This bill ensures that vulnerable children, such as those on Medi-Cal, are receiving blood lead tests by creating the necessary accountability mechanisms to ensure compliance and proper tracking of existing blood lead test mandates. This bill also requires DPH to update its Local Prevention Program Funding Allocation Methodology to guarantee a more equitable distribution of funds and adds several known risk factors for lead poisoning to ensure that our children receive the proper care under the CLPPP.
- State Auditor report. In January 2020, California’s State Auditor completed its audit report of DHCS and DPH, which focused on both the administration of lead tests to children in Medi-Cal and the activities of CLPPP. The audit determined that millions of children in Medi-Cal are not receiving the lead tests they should be receiving, and DPH is not prioritizing the prevention of lead poisoning. The audit found that from fiscal years 2009–10 through 2017–18, more than 1.4 million of the 2.9 million one- and two-year-old children enrolled in Medi-Cal did not receive any of the required tests, and another 740,000 children missed one of the two required tests. As a result, the rate of eligible children receiving all of the tests that they should have was less than 27%. Without these tests, health care providers do not know whether these children are suffering from elevated lead levels and need treatment. Despite low lead testing rates, DHCS has only recently begun developing an incentive program to increase testing and a performance standard for measuring the extent to which managed care plans are providing the tests. The audit also found that DPH, and the CLPPP, does not focus on proactive abatement of lead hazards to prevent future poisoning. Finally, DPH has failed to meet several legislative requirements, including a mandate to update the factors that health care providers must use to determine whether a child is at risk of lead exposure, which help them identify children who need testing.
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: No
According to the Senate Appropriations Committee:
- DHCS. Staff notes unknown, significant ongoing administrative costs (high hundreds of thousands to low millions General Fund [GF]/federal fund) for additional resources and ongoing workload to monitor health plan compliance with contracts, including its communication to families about blood lead screening tests, data reporting, and meeting specified state goals.
- DPH. Staff notes indeterminate, significant ongoing administrative costs (low to mid- hundreds of thousands, GF) in staff resources to conduct a review of existing CLPPP funding levels and revise allocation formulas, as needed. Costs to promulgate additional regulations may be short-term.
SUPPORT: (Verified 8/21/20)
Environmental Working Group (co-source)
California Coalition of Welfare Rights Organizations (co-source)
Western Center on Law and Poverty (co-source)
American Academy of Pediatrics, California
Association of Regional Center Agencies
California League of Conservation Voters
California Pan-Ethnic Health Network
California Society of Health-System Pharmacists
CalPIRG
Center for Environmental Health
Children Now
Children’s Defense Fund-California
Clean Water Action
Community Clinic Association of Los Angeles County
Environmental Health Coalition
Friends Committee on Legislation of California
Healthy Black Families, Inc.
Maternal and Child Health Access
National Association of Social Workers, California Chapter
National Health Law Program
Natural Resources Defense Council
Sierra Club California
Smart Oakland
OPPOSITION: (Verified 8/21/20)
Department of Finance
ARGUMENTS IN SUPPORT: This is bill sponsored by Environmental Working Group, California Coalition of Welfare Rights Organizations, and Western Center on Law and Poverty, which write in a joint letter that all children can be exposed to lead, but, according to CDPH, the vast majority of California’s lead-poisoned kids are enrolled in Medi-Cal. Low-income kids are more apt to be lead-poisoned because they are more likely to live in older housing with lead paint, and be malnourished, which causes them to absorb lead faster. If not stopped, a child’s ongoing exposure to lead will continue to harm their nervous system, and cause damage that can last a lifetime. California must and should identify as many lead-exposed children as the law requires. At the minimum, DHCS should ensure that the established lead-testing requirement for Medi-Cal recipient children is met, and DHCS should develop a system to track these children’s’ blood lead tests and follow-up services. In addition, parents and healthcare providers of Medi-Cal children should be informed when a child has missed a required test, and DPH testing requirements as well as funding distribution formulas for local CLPP programs should be updated.
ARGUMENTS IN OPPOSITION: Department of Finance is opposed to this bill because it would result in significant GF costs not included in the 2020 Budget Act and is duplicative of efforts currently underway by DHCS and DPH described in the state auditor’s report.
ASSEMBLY FLOOR: 78-0, 6/10/20
AYES: Aguiar-Curry, Arambula, Bauer-Kahan, Berman, Bigelow, Bloom, Boerner Horvath, Bonta, Brough, Burke, Calderon, Carrillo, Cervantes, Chau, Chen, Chiu, Choi, Chu, Cooley, Cooper, Cunningham, Megan Dahle, Daly, Diep, Eggman, Flora, Fong, Frazier, Friedman, Gabriel, Gallagher, Cristina Garcia, Eduardo Garcia, Gipson, Gloria, Gonzalez, Gray, Grayson, Holden, Irwin, Jones-Sawyer, Kalra, Kamlager, Kiley, Lackey, Levine, Limón, Low, Maienschein, Mathis, Mayes, McCarty, Medina, Mullin, Muratsuchi, Nazarian, Obernolte, O'Donnell, Patterson, Petrie-Norris, Quirk-Silva, Ramos, Reyes, Luz Rivas, Robert Rivas, Rodriguez, Blanca Rubio, Salas, Santiago, Smith, Mark Stone, Ting, Voepel, Waldron, Weber, Wicks, Wood, Rendon
NO VOTE RECORDED: Quirk
Prepared by: Kimberly Chen / HEALTH / (916) 651-4111
8/25/20 10:04:53
SENATE COMMITTEE ON HEALTH
Senator Dr. Richard Pan, Chair
BILL NO: AB 2276
AUTHOR: | Reyes, Cristina Garcia, Quirk, Salas | ||
VERSION: | July 27, 2020 | ||
HEARING DATE: | August 1, 2020 | ||
CONSULTANT: | Kimberly Chen and Teri Boughton | ||
SUBJECT: Childhood lead poisoning: screening and prevention
SUMMARY:
Creates additional risk factors to be considered by health care providers evaluating children at risk of lead poisoning, and requires the California Department of Public Health to update its formula for allocating funds to local Childhood Lead Poisoning Prevention Programs. Establishes blood lead screening tests goals for the Medi-Cal program. Requires the Department of Health Care Services to meet and report progress on meeting blood lead screening test goals. Requires Medi-Cal managed care plans to notify the family and health care providers of children on Medi-Cal about blood lead screening requirements and whether children have missed required blood lead screening tests.
Existing law:
- Establishes the Childhood Lead Poisoning Prevention Act of 1991. [HSC §105275]
- Requires the California Department of Public Health (DPH) to adopt regulations establishing a standard of care, at least as stringent as the most recent federal Centers for Disease Control and Prevention (CDC) screening guidelines, whereby all children are evaluated for risk of lead poisoning by health care providers during each child’s periodic health assessment. [HSC §105285]
- Requires the regulations to include the determination of risk factors for whether a child is “at risk,” and consider the most significant environmental risk factors, including, but not limited to, all of the following:
- A child’s time spent in a home, school, or building built before 1978;
- A child’s proximity to a former lead or steel smelter or an industrial facility that historically emitted or currently emits lead;
- A child’s proximity to a freeway or heavily traveled roadway; and,
- Other potential risk factors for lead exposure, and known sources of lead contamination. [HSC §105285]
- Requires DPH to ensure appropriate case management when a child is identified with lead poisoning, and permits DPH to contract with any public or private entity, including local agencies, to conduct the case management. [HSC §105290]
- Requires DPH to collect and analyze all information necessary to effectively monitor appropriate case management efforts. Requires DPH to prepare a biennial report describing the effectiveness of appropriate case management efforts, and make it available to local health departments and the general public. [HSC §105290]
- Gives DPH broad regulatory authority to fully implement and effectuate the Child Lead Poisoning Prevention Program (CLPPP) including, but not limited to, the following:
- The development of protocols to be utilized in screening and the procedures for changing those protocols when more accurate or efficient technologies become available;
- The designation of laboratories which are qualified to analyze whole blood specimens for concentrations of lead and the monitoring of those laboratories for accuracy;
- The development of reporting procedures by laboratories;
- The reimbursement for state-sponsored services related to screening and appropriate case management;
- The establishment of lower concentrations of lead in whole blood than those specified by the United States Centers for Disease Control (CDC) for the purpose of determining the existence of lead poisoning;
- The establishment of lower acceptable levels of the concentration of lead in whole blood than those specified by the CDC for the purpose of determining the need to provide appropriate case management for lead poisoning;
- The development of appropriate case management protocols;
- The notification to the child’s parent or guardian of the results of blood lead testing and environmental assessment; and,
- The establishment of a periodicity schedule for evaluation for childhood lead poisoning. [HSC §105300]
- Establishes the Medi-Cal program, which is administered by the Department of Health Care Services (DHCS) and under which qualified low-income individuals receive health care services. [WIC §14000, et seq.]
- Establishes a schedule of benefits in the Medi-Cal program, including the Early and Periodic Screening, Diagnostic and Treatment (EPSDT) program that requires testing and treatment for elevated blood lead levels for children at 12 month and 24 months of age, consistent with the requirements of the federal Medicaid program. [WIC §14132]
This bill:
- Adds to the determination of risk factors to be considered by health care providers evaluating children at risk of lead poisoning, the following:
- A child’s residency in or visit to a foreign country;
- A child’s residency in a high-risk ZIP Code;
- A child who has a sibling or playmate with lead poisoning;
- The likelihood of a child placing nonfood items in the mouth;
- A child’s proximity to current or former lead-producing facilities; and,
- The likelihood of a child using food, medicine, or dishes from other countries.
- Requires regulations to be developed by January 1, 2021 in consultation with medical experts, environmental experts, appropriate professional organizations, the public, and others as determined by DPH.
- Requires DPH to update its formula for allocating funds to any local agency that contracts with DPH to administer CLPPP to ensure that funds are allocated equitably and commensurate with the level of services needed to provide to children with elevated blood levels, and to revise funding allocations before each contract cycle. Requires DPH to take into account the most recent data for the number of children with elevated blood lead levels in each jurisdiction when revising the allocation formula.
- Defines “elevated blood levels” as a blood lead level that is no higher than the blood lead reference value as specified in the most recent guidelines issued by CDC.
- Requires the EPSDT benefit for Medi-Cal to include the following goals:
- Every child at risk of lead exposure receives blood lead screening tests, consistent with existing law;
- Every child who is eligible for services under the Medi-Cal program receives blood lead screening tests at 12 and 24 months of age, consistent with existing regulations; and,
- Every child, between two and six years of age, who is eligible for services under the Medi-Cal program, and for whom there is no record of a previous blood lead screening test, receives at least one blood lead screening test pursuant to the most recent guidelines published by the CDC.
- Requires DHCS to annually post on its Medi-Cal dashboards on its website a report detailing DHCS’ progress toward the goals specified in 5) above. Requires the report to include the number of Medi-Cal beneficiaries in each county who have and have not received blood lead screening tests, identified by the following age groups:
- Newborn to one year of age, inclusive;
- One year and one day to two years of age, inclusive; and,
- Two years and one day to six years of age, inclusive.
- Requires DHCS to ensure the following for a Medi-Cal beneficiary who is a child, consistent with existing regulations:
- A child receives a blood lead screening test at 12 and 24 months of age; and,
- A child between two and six years of age, who does not have a record of a previous blood lead screening test, receives at least one blood lead screening.
- Requires a Medi-Cal managed care plan (MCP), in order to comply with blood lead screening test requirements, to do all of the following:
- Establish a monitoring system that includes standard reporting requirements that comply with guidelines established by DHCS and ensures each child receives required blood lead screening tests. Requires DHCS to solicit from stakeholders, including consumer advocates and representatives, when establishing the guidelines for the monitoring system’s standard reporting requirement;
- Identify, on a quarterly basis, every beneficiary six years of age or younger that has missed a required blood lead screening and identify the age at which the required blood lead screenings were missed, including which children are without any record of a completed blood lead screening at each age;
- Notify the child’s health care provider when the child misses a required blood lead screening test. Requires the notification to be sent within 30 days of the missed test;
- Report data to DHCS on the number of children six years of age and young, by each age, who have received a blood lead screening test;
- Require its contracting health care providers who are responsible for performing a periodic health assessment of a child to test each child, consistent with state and federal law, regulations, and DHCS’s Blood Lead Test and Anticipatory Guidance guidelines;
- Notify its contracting health care providers of the requirement to perform periodic child health assessments and blood led tests;
- Notify the parent, guardian, or other person charged with the support and maintenance of a child under the age of six, at the time the child becomes a Medi-Cal beneficiary and annually thereafter, all of the following:
- The risks and effects of lead exposure;
- The requirement for a child to receive blood lead screening tests at age appropriate intervals;
- The recommendation that a child receive a blood lead screening test if they are at risk of lead exposure; and,
- A notification of a missed screening, if the child missed a required blood lead screening test. Requires the notification to be included in an annual notice to the family of a child who has not used preventive services in the course of the year; and,
- Notify the child’s parent, parents, guardian, or other person charged with the support and maintenance of that child when the child misses a required blood lead screening test at 12 and 24 months of age. Requires the notification to be included in an annual notification to each family of a child who has not used preventive services over the course of the year.
- Requires the contract between DHCS and a Medi-Cal MCP to include the requirements of 8) above.
FISCAL EFFECT:
According to the Assembly Appropriations Committee:
- Costs to DPH to add additional risk factors into a planned rulemaking are minor and absorbable (Childhood Lead Poisoning Prevention Fund).
- Ongoing administrative costs to DHCS in the hundreds of thousands of dollars annually to monitor health plan compliance with contracts and progress towards goals, and to report data (General Fund (GF) /federal).
- Significant costs of an unknown amount to prepare and mail information annually to all families with young children about blood lead screening tests (GF/federal). According to a state audit further discussed below, DHCS is already working on a targeted outreach campaign to inform beneficiaries about the availability of a range of recommended children’s preventive health care services under Medi-Cal and how to access them. Part of this outreach will include highlighting the availability of blood lead screening tests. This bill would make such outreach efforts permanent and ongoing, for purposes of blood lead screening.
- Unknown, significant costs associated with increased capitation (per-member, per-month) payments to Medi-Cal MCPs. This bill would require individual-level tracking and follow-up for each missed test. Administrative costs for each contracting plan to develop its own monitoring system to track blood lead tests for children enrolled in Medi-Cal are unknown but significant. Because capitation payments are developed based on Medi-Cal MCPs’ costs to serve Medi-Cal beneficiaries, these increased administrative costs to Medi-Cal MCPs would be passed on to the state through higher capitation payments (GF/federal).
- $600,000 in administrative staff costs annually to the DHCS (GF/federal) to implement and oversee compliance with the required contracting and contractual monitoring activities. The infrastructure for many of these requirements is already in place pursuant to existing DHCS activities undertaken prior to and in response to a recent state audit, described more fully below. This bill would codify these activities, requiring them to continue in future years.
PRIOR VOTES:
(note – this bill combines the provisions of three bills that were heard in the Assembly)
AB 2276
Assembly Floor: 78-0
Assembly Appropriations Committee: 18-0
Assembly Health Committee: 15-0
AB 2277
Assembly Floor: 77-0
Assembly Appropriations Committee: 18-0
Assembly Health Committee: 15-0
AB 2279
Assembly Floor: 76-0
Assembly Appropriations Committee: 18-0
Assembly Health Committee: 15-0
COMMENTS:
- Author’s statement. According to the author, protecting the state’s most vulnerable must be a top priority for the Legislature. Studies have shown that lead exposure disproportionately impacts low income communities, and that the damage can cause cognitive disabilities and other forms of irreparable harm. A report released by the State Auditor found that more than 1.4 million one and two year old children did not receive any of the required tests and noted California ranks 31st in the nation for providing lead tests to one and two year olds. The failure to ensure that millions of children enrolled in Medi-Cal receive the required lead testing puts the health and safety of our most vulnerable populations at risk for lead poisoning. This bill ensures that vulnerable children, such as those on Medi-Cal, are receiving blood lead tests by creating the necessary accountability mechanisms to ensure compliance and proper tracking of existing blood lead test mandates. This bill also requires DPH to update its Local Prevention Program Funding Allocation Methodology to guarantee a more equitable distribution of funds and adds several known risk factors for lead poisoning to ensure that our children receive the proper care under the CLPPP.
- Lead exposure in children. According to the DPH and the CDC, lead is a naturally occurring metal that has been used in many products and is harmful to the human body. Lead was once used in paints, gasoline, and vinyl products. In the United States, lead is still used to make batteries, ammunition, some metal pipes, and devices to shield x-rays. People may be exposed to lead by breathing or swallowing lead or lead dust. Once it enters the body, lead can become a health hazard. Lead can affect almost every organ and system in the body, especially the nervous system. It can cause learning disabilities and behavioral problems. At very high levels, it can cause seizures, coma, and even death. Lead poisoning frequently goes unrecognized because it often occurs with no obvious symptoms.
Children under six years old and fetuses are at greatest risk of harmful health effects from lead poisoning as their brains and nervous systems are still forming. The normal behavior of children under six years old is crawling, exploring, teething, and putting objects in their mouth. This puts them into contact with any lead that is present in their environment, including floors, furniture, or objects contaminated with lead dust. Children may eat paint chips or chew on the surfaces of cribs, highchairs, windows, woodwork, walls, doors, or railings that contain lead. Lead may be in the soil where children play, especially near busy roadways or factories. Lead can be measured in their blood and remains in their bodies for a long time. For instance, the lead from gasoline used for many years has settled onto soil and is difficult to remove. This soil may also be tracked inside on shoes and clothing. Some countries other than the United States still allow lead sold in food cans and other products. Home remedies, cosmetics, pottery, candies or foods, and tableware may contain lead. Lead has also been found in inexpensive children’s jewelry sold in vending machines across the country.
There is no known safe level of lead. The primary way to determine whether a child has been exposed to lead is to perform a blood test to measure the level of lead in a person’s blood, expressed in micrograms per deciliter.
- Blood lead screening requirements and services. State and federal laws and regulation require health care providers, DHCS and DPH to perform certain responsibilities in blood lead screening for children and providing services to children with elevated blood lead levels.
State regulations and federal law requires providers to perform a blood lead test on children on Medi-Cal at 12 months and 24 months of age, or at any periodic assessment up to the age six if the provider learns the child has no history of receiving required blood lead testing. Under EPSDT, a federally mandated benefit available to all Medi-Cal eligible individuals under the age of 21, Medi-Cal is required to provide comprehensive services and cover all medically necessary services needed to correct and ameliorate health conditions, including a requirement for blood lead testing at 12 months and 24 months of age. Moreover, DHCS has adopted the Bright Futures periodicity schedule, which are recommendations for periodic, preventive care screenings and well-child visits for children developed by the American Academy of Pediatrics, and requires children between 24 months and six years of age to be assessed for blood lead exposure and tested accordingly. This includes requiring the child be tested when the provider determines any changes in the child’s environment or life that may result in blood lead exposure.
For children not covered by Medi-Cal, state regulations requires providers to test for blood lead levels based on the provider’s evaluation of the child’s risk for lead exposure. State regulations require the family of all children six years old and under, regardless of whether they are on Medi-Cal or not, to be informed about lead poisoning at periodic health assessments. For providers and MCPs serving children on Medi-Cal, DHCS has developed All-Plan Letters and guidance for evaluating, testing, and managing care for children with lead poisoning. The Blood Lead Test and Anticipatory guidelines, for instance, includes recommended and required service referrals when a child is identified to have elevated blood lead levels at certain thresholds.
State law requires DPH to oversee the statewide lead prevention program, which is funded by fees collected from manufacturers that contribute to environmental lead contamination. When blood lead screening tests identify a child at a specified threshold of elevated blood lead levels, DPH must ensure the child receives appropriate case management services, including nutritional assessments, home visits, and environmental investigation. DPH provides the case management services directly or contracts with local health departments to do so. According to the State Auditor, DPH currently contracts with 50 local prevention programs, which covers 97% of children with elevated blood lead levels. In some cases, the local program provides nutritional assessment and home visits while DPH conducts the environmental assessment.
- State Auditor report. In January 2020, California’s State Auditor completed its audit report of DHCS and DPH focused on both the administration of lead tests to children in Medi-Cal and the activities of CLPPP. The audit determined that millions of children in Medi-Cal are not receiving the lead tests they should be receiving, and DPH is not prioritizing the prevention of lead poisoning. The audit found that from fiscal years 2009–10 through 2017–18, more than 1.4 million of the 2.9 million one- and two-year-old children enrolled in Medi-Cal did not receive any of the required tests, and another 740,000 children missed one of the two required tests. As a result, the rate of eligible children receiving all of the tests that they should have was less than 27%. Without these tests, health care providers do not know whether these children are suffering from elevated lead levels and need treatment. Despite low lead testing rates, DHCS has only recently begun developing an incentive program to increase testing and a performance standard for measuring the extent to which managed care plans are providing the tests. The audit also found that DPH, and the CLPPP, does not focus on proactive abatement of lead hazards to prevent future poisoning. Instead, DPH delegates to local prevention programs, and requires them to monitor abatement in the homes of children who have already suffered lead poisoning. However, such efforts only prevent future poisoning in those specific homes. Although DPH claims that the local prevention programs are reducing lead exposure through education and outreach, it could not demonstrate the effectiveness of this outreach. Finally, DPH has failed to meet several legislative requirements, including a mandate to update the factors that health care providers must use to determine whether a child is at risk of lead exposure, which help them identify children who need testing.
- Recommendations for DHCS. Because of the severe and potentially permanent damage that lead poisoning can cause in children, the State Auditor recommends DHCS ensure that all children in Medi-Cal receive lead tests by finalizing its performance standard for lead testing of one- and two-year-olds. DHCS should use existing data to assess the progress of Medi-Cal MCPs in meeting that performance standard and impose sanctions or provide incentive payments as appropriate to improve performance. To ensure that families know about the lead testing services that their children are entitled to receive, the State Auditor recommends DHCS to remind families of children who have missed lead tests to get a lead test and for DHCS to include the reminder in the annual notification to families of children who missed preventive services. To increase California’s lead testing rates and improve lead test reporting, the DHCS should incorporate into its contracts with Medi-Cal MCPs a requirement for the plans to identify each month all children with no record of receiving a required test and remind the responsible health care providers of the requirement to test the children. Finally, the State Auditor recommends DHCS develop and implement a procedure to hold Medi-Cal MCPs accountable for meeting these requirement.
- Recommendations for DPH. To identify the highest priority areas for using resources to alleviate lead exposure among children, the State Auditor recommends DPH immediately complete and publicize an analysis of high-risk areas throughout the State. To ensure that local prevention programs’ outreach results in a reduced number of children with lead poisoning, DPH should require local prevention programs to demonstrate the effectiveness of their outreach in meeting this goal. If the local prevention programs are unable to demonstrate the effectiveness of their outreach in reducing the number of children with lead poisoning, DPH should analyze the cost-effectiveness of other approaches, including proactive abatement, and require the local prevention programs to replace or augment outreach to the extent resources allow.
To better ensure that children with lead poisoning are identified and treated, DPH should prioritize finishing the development of the lead risk evaluation regulations and include in them multiple risk factors, such as those used in lead risk evaluation questionnaires in other states. It should also commence the formal rulemaking process. DPH should also provide guidance to health care providers about the risks of childhood lead exposure and statutory requirements related to lead testing. To ensure a more equitable distribution of resources for treating children with lead poisoning, DPH should, by June 2020, update its methodology for allocating funds to local prevention programs, including accounting for the most recent annual count of children with lead poisoning in each jurisdiction. DPH should revise the allocations before each contract cycle.
- Related legislation. AB 2277 (Salas) requires Medi-Cal MCPs to identify and notify the family and providers of children who have missed required blood lead screening tests at 12 months and 24 months of age. The provisions of AB 2277 have been amended into this bill.
AB 2279 (Garcia) creates additional risk factors to be considered by health care providers evaluating children at risk of lead poisoning, and requires the DPH to update its formula for allocating funds to local CLPPP. The provisions AB 2279 have been amended into this bill.
- Prior legislation. SB 1041 (Leyva, Chapter 690, Statutes of 2018) requires DPH to annually notify health care providers who perform periodic health assessments for children about, and requires those health care providers to inform parents and guardians about, the risks and effect of childhood lead exposure, and the requirement that children enrolled in Medi-Cal receive blood screening tests. Requires DPH to include additional publicly releasable information about the number of children enrolled in Medi-Cal who have and have not received blood lead screening tests.
SB 1097 (Hueso, Chapter 691, Statutes of 2018) requires the DPH report regarding the effectiveness of appropriate lead poisoning case management efforts to include additional data and information, as specified.
AB 2122 (Reyes of 2018) would have established requirements for DHCS and Medi-Cal managed care plans to ensure children receive blood lead screening, information about lead exposure and testing, and follow-up services for children with an elevated blood lead level, including a contractual requirement for plans and their contractors to meet the standard of care for lead testing; established state goals for children at risk of lead exposure and for blood testing for children under age who are eligible for Medi-Cal; required DHCS to include blood lead screening tests as a plan performance measure in its annual External Accountability Set, and requires DHCS to annually create a report detailing the DHCS’ progress toward the state goals; and required DPH to prepare provider training guidelines, curriculum, and resources that are required to be used to educate providers about childhood lead poisoning prevention, childhood lead exposure risks, childhood lead exposure health effects, and sources of childhood lead exposure at the state, regional, and local levels. AB 2122 was vetoed by Governor Brown, who stated, in part: “Lead exposure in children is a serious health concern and I share the author's desire to increase the number of Medi-Cal children who are screened. The department, however, already requires in its contracts with managed care plans and providers that children receive screenings in accordance with federal and state regulations. Updated and more thorough data on periodic screening tests is being developed with DPH to assist in tracking compliance.”
AB 1316 (Quirk and Garcia, Chapter 507, Statutes of 2017) requires CLPPP regulations to include a risk assessment for determining whether a child is “at risk” that considers the most significant environmental risk factors, including, a child’s time spent in a home, school, or building built before 1978, a child’s proximity to a former lead or steel smelter, or industrial facility that historically emitted or currently emits lead, a child’s proximity to a freeway or heavily traveled roadway, and other potential risk factors for lead exposure.
AB 247 (Garcia of 2017) would have established a Statewide Lead Advisory Taskforce to review and provide recommendations regarding policies and procedures to reduce lead poisoning in the state. AB 247 was vetoed by Governor Brown, who stated: “The responsibilities of this task force would be duplicative of ongoing work by the Office of Environmental Health Hazard Assessment, DPH, the State Water Resources Control Board, and the Department of Toxic Substances Control. Coordination and evaluation of procedures to reduce childhood lead poisoning is being accomplished administratively amongst these agencies so there is no reason to divert resources to a task force.”
AB 2976 (Quirk of 2017) would have required DPH to coordinate with the state entities, including the DHCS, that are responsible for administering the publicly funded programs to gather data to determine whether children are being screened for lead poisoning, as required by pursuant to existing regulation AB 2976 was held on the Senate Appropriations suspense file.
SB 775 (Ridley-Thomas of 2017) would have required DPH make available to all health care providers current information about lead and lead poisoning and to report on the state’s lead poisoning prevention programs. SB 775 would have required health care providers, when providing services to a child who receives services from a publicly funded program for low-income children, to conduct or provide a referral for a blood lead test and to document the assessment and screening in the child’s immunization record. SB 775 was vetoed by Governor Schwarzenegger, who stated that the bill’s provisions are duplicative and are already being accomplished administratively.
- Support. This is bill sponsored by Environmental Working Group, California Coalition of Welfare Rights Organizations, and Western Center on Law and Poverty, which write in a joint letter that all children can be exposed to lead, but, according to CDPH, the vast majority of California’s lead-poisoned kids are enrolled in Medi-Cal. Low-income kids are more apt to be lead-poisoned because they are more likely to live in older housing with lead paint, and be malnourished, which causes them to absorb lead faster. If not stopped, a child’s ongoing exposure to lead will continue to harm their nervous system, and cause damage that can last a lifetime. California must and should identify as many lead-exposed children as the law requires. At the minimum, DHCS should ensure that the established lead-testing requirement for Medi-Cal recipient children is met, and DHCS should develop a system to track these children’s’ blood lead tests and follow-up services. In addition, parents and healthcare providers of Medi-Cal children should be informed when a child has missed a required test, and DPH testing requirements as well as funding distribution formulas for local CLPP programs should be updated.
This bill is also supported by the California Pan-Ethnic Health Network (CPEHN). CPEHN states that a majority of children at risk for lead poisoning are not receiving the necessary health interventions. CPEHN supports this bill because it addresses outdated regulations for childhood blood lead screenings and pursues equitable health outcomes.
- Amendments. This bill requires Medi-Cal MCPs to notify providers within 30 days if a child missed a required blood lead test. Notifying providers within 30 days could erroneously flag children who did receive tests but whose provider has not yet submitted the encounter to the MCP. The Committee proposes the following amendments to change the provider notification from within 30 days of a missed test to quarterly, in order to avoid erroneous notifications and to allow for batch reporting, and to make a technical change.
- Notification to providers: On page 2, line 6-8, amend paragraph (b)(2)(B) as follows: “Notify the child’s health care provider when the child misses a required blood lead screening test. This notification shall be sent
within 30 days of the missed testquarterly to the health care providers of children who have missed a required blood lead screening test.” - Technical amendments to streamline language: On page 21, line 38 to page 22, line 2, amend paragraph (b)(6)(D) as follows: “If the child missed a required blood lead screening test, including required blood lead screening test at 12 and 24 months of age, a notification of the missed screening test included in annual notification to the family for a child who has not used preventive services in the course of the year.”
- Notification to providers: On page 2, line 6-8, amend paragraph (b)(2)(B) as follows: “Notify the child’s health care provider when the child misses a required blood lead screening test. This notification shall be sent
On page 23, line 4-9, delete paragraph (b)(7). The provisions of this paragraph will be included as part of (b)(6)(D) in the amendment above.
SUPPORT AND OPPOSITION:
Support: Environmental Working Group (sponsor)
California Coalition of Welfare Rights Organizations (sponsor)
Western Center on Law and Poverty (sponsor)
American Academy of Pediatrics, California
Association of Regional Center Agencies
California League of Conservation Voters
California Pan-Ethnic Health Network
California Society of Health-System Pharmacists
CalPIRG
Center for Environmental Health
Children Now
Children’s Defense Fund-California
Clean Water Action
Community Clinic Association of Los Angeles County
Environmental Health Coalition
Friends Committee on Legislation of California
Healthy Black Families, Inc.
Maternal and Child Health Access
National Association of Social Workers, California Chapter
National Health Law Program
Natural Resources Defense Council
Sierra Club California
Smart Oakland
Oppose: None received
-- END --
SENATE COMMITTEE ON APPROPRIATIONS
Senator Anthony Portantino, Chair
2019 - 2020 Regular Session
AB 2276 (Reyes) - Childhood lead poisoning: screening and prevention
Version: August 5, 2020 | Policy Vote: HEALTH 8 - 0 |
Urgency: No | Mandate: No |
Hearing Date: August 20, 2020 | Consultant: Samantha Lui |
Bill Summary:
Assembly Bill 2276 would require the Department of Health Care Services (DHCS) to ensure a child receiving Medi-Cal receives blood lead screening tests at specified intervals. Would require Medi-Cal managed care plans to establish a monitoring system and provide specified notifications to families. Would require the Department of Public Health (CDPH) to update, and revise, as specified, its funding allocation formula to a local agency who contacts with the department to administer the Childhood Lead Poisoning Prevention program (CLPP).
*********** ANALYSIS ADDENDUM – SUSPENSE FILE ***********
The following information is revised to reflect amendments
adopted by the committee on August 20, 2020
Fiscal Impact:
- DHCS. Staff notes unknown, significant ongoing administrative costs (high hundreds of thousands to low millions General Fund/federal fund) for additional resources and ongoing workload to monitor health plan compliance with contracts, including its communication to families about blood lead screening tests, data reporting, and meeting specified state goals.
- CDPH. Staff notes indeterminate, significant ongoing administrative costs (low to mid- hundreds of thousands, General Fund) in staff resources to conduct a review of existing CLPPP funding levels and revise allocation formulas, as needed. Costs to promulgate additional regulations may be short-term.
Author Amendments:
The author’s amendment would remove the requirement for a Medi-Cal managed care plan to establish a monitoring system that includes standard reporting, and for the DHCS to solicit input from stakeholders when establishing the guidelines for the monitoring system’s standard reporting requirement.
-- END --
SENATE COMMITTEE ON
Senator Anthony Portantino, Chair
2019 - 2020 Regular Session
AB 2276 (Reyes) - Childhood lead poisoning: screening and prevention
Version: | Policy Vote: |
Urgency: | Mandate: |
Hearing Date: | Consultant: |
Bill Summary:
Assembly Bill 2276 would require the Department of Health Care Services (DHCS) to ensure a child receiving Medi-Cal receives blood lead screening tests at specified intervals. Would require Medi-Cal managed care plans to establish a monitoring system and provide specified notifications to families. Would require the Department of Public Health (CDPH) to update, and revise, as specified, its funding allocation formulato a local agency who contacts with the department to administer the Childhood Lead Poisoning Prevention program (CLPP).
Fiscal Impact:
- DHCS. Staff notes unknown, significant ongoing administrative costs (high hundreds of thousands to low millions General Fund/federal fund) for additional resources and ongoing workload to monitor health plan compliance with contracts, including its communication to families about blood lead screening tests, data reporting, and meeting specified state goals.
In addition, staff notes unknown, significant, ongoing costs with likely increased capitation rates (potentially $1 – 5 million, General Fund/federal fund) to managed care plans to develop monitoring systems for individual tracking and follow-up. Because capitation payments are developed based on Medi-Cal managed care plans’ costs, these increased administrative costs would be passed on to the state through higher capitation payments.
- CDPH. Staff notes indeterminate, significant ongoing administrative costs (low to mid- hundreds of thousands, General Fund) in staff resources to conduct a review of existing CLPPP funding levels and revise allocation formulas, as needed. Costs to promulgate additional regulations may be short-term.
Background:
The Childhood Lead Poisoning Prevention (CLPP) program at CDPH was established in 1986 to reduce the incidence of childhood lead exposure in California. The program focuses on young children at increased risk for lead exposure, including those living in older housing stock with leadbased paint or lead-contaminated dust and soil. Children at high risk of exposure are required to be blood tested for lead and children with high blood lead levels are eligible for CLPP services. Under current law, health plans and health insurers must provide coverage for screening for blood lead levels for children who are at risk of lead poisoning. In addition, all children enrolled in Medi-Cal must have their blood tested for lead at 12 and 24 months.
There are 43 local CLPP programs in 40 counties and three cities that provide services to eligible children under a contract with CDPH. The state CLPP program provides services to eligible children in the remaining 18 counties. These services include outreach to populations at high risk of lead exposure, educational and other services for children with high blood lead levels, full public health nursing and environmental services to children with lead poisoning, and follow-up to ensure sources of lead exposure are removed. The state CLPP program also provides information on laboratory reported lead tests to local CLPP programs; and statewide surveillance, data analysis, oversight, outreach and technical assistance for all counties. The CLPP program’s current electronic information system, RASSCLE 2, supports the receipt of laboratory lead testing results and the management and monitoring of lead-exposed children. The CLPP is supported by a fee assessed on businesses whose products currently contain lead or formerly contained lead, such as paint manufacturers.
In January 2020, California’s State Auditor released its report of DHCS and CDPH’s administration of lead tests to children in Medi-Cal and the activities of CLPPP. The audit determined from FY 2009–10 through 2017–18, more than 1.4 million of the 2.9 million one- and two-year-old children enrolled in Medi-Cal did not receive any of the required tests, and another 740,000 children missed one of the two required tests. The audit also found that CDPH’s current funding formula to local prevention programs was based on outdated information on the number of children with lead poisoning in each jurisdiction, which led to service differences.
Proposed Law:
Medi-Cal blood lead level screening for children. The bill would establish state goals for blood lead screening tests for children and require the DHCS to annually post on its website a report detailing progress toward the goals.
The bill also would require DHCS to ensure, with respect to a Medi-Cal beneficiary who is a child, and consistent with the existing state regulations, both of the following:
- A child must receive a blood lead screening test at 12 and 24 months of age pursuant to that regulation.
- A child between two and six years of age, inclusive, for whom there is no record of a previous blood lead screening test, must receive at least one blood lead screening pursuant to that regulation.
The bill would require each Medi-Cal managed care plan, and DHCS to include in its contract with the managed care plan, to do all of the following:
- Establish a monitoring system that must ensure each child receives required blood lead screening tests. Require the DHCS to solicit input from stakeholders when establishing the guidelines for the monitoring system’s standard reporting requirement.
- Report data to the DHCS on the number of children six years of age and younger, by each age, who have received a blood lead screening test.
- Require and notify its contracting health care providers to test each child pursuant to state and federal law, regulations, and guideline.
- Inform the child’s parent, parents, guardian, or other person charged with their support and maintenance, at the time that a child under six years of age becomes a beneficiary under the Medi-Cal program, and annually thereafter, up to six years of age.
- Notify the family of a missed screening test.
The bill also would add additional environmental risk factors it must consider for whether a child is “at risk” of lead poisoning to include the following:
- A child’s residency in or visit to a foreign country.
- A child’s residency in a high-risk ZIP Code.
- A child who has a sibling or playmate with lead poisoning.
- The likelihood of a child placing nonfood items in the mouth.
- A child’s proximity to current or former lead-producing facilities.
- The likelihood of a child using food, medicine, or dishes from other countries.
The bill would require, by January 1, 2021, specified regulations to be developed in consultation with specified individuals.
Childhood Lead Poisoning Prevention program funding. The bill would require CDPH to update its formula for allocating funds to a local agency that contracts with the department to administer the CLPP, and revise those funding allocations before each contract cycle. In addition, the CDPH must take into account the most recent data for the number of children with elevated blood lead levels in each jurisdiction when revising the allocation formula.
Related Legislation:
AB 2277 (Salas) requires Medi-Cal managed care plans to identify and notify the family and providers of children who have missed required blood lead screening tests at 12- and 24 months of age. The provisions of AB 2277 were amended into this bill.
AB 2279 (Garcia) creates additional risk factors to be considered by health care providers when evaluating children at risk of lead poisoning, and requires the CDPH to update its formula for allocating funds to local CLPPP. The provisions of AB 2279 were amended into this bill.
SB 1041 (Leyva, Chapter 690, Statutes of 2018) requires CDPH to annually notify health care providers who perform periodic health assessments, and requires those providers to inform parents and guardians, about the risks of childhood lead exposure, and the requirement that children enrolled in Medi-Cal receive blood screening tests.
AB 2122 (Reyes, 2018) would have established requirements for DHCS and Medi-Cal managed care plans to ensure children receive blood lead screening, information about lead exposure and testing, and follow-up services. AB 2122 was vetoed by Governor Brown, who stated, in part: “The department, however, already requires in its contracts with managed care plans and providers that children receive screenings in accordance with federal and state regulations. Updated and more thorough data on periodic screening tests is being developed with DPH to assist in tracking compliance.”
-- END --
ASSEMBLY THIRD READING
ATR Bill Id:AB 2276
Author:(Reyes, et al.)
As Amended Ver:May 12, 2020
Majority vote
SUMMARY:
Establishes statutory state goals for blood lead screening tests for children, and requires the Department of Health Care Services (DHCS) to annually post on its internet website a report detailing its progress toward the goals. Requires a contract between DHCS and a Medi-Cal managed care (MCMC) plan to ensure that the MCMC plan and its contracting health care providers who are responsible for the period health assessment of a child pursuant to state regulation meet the standard of care for lead-related anticipatory guidance, screening and evaluation required pursuant to state law and regulation. Requires the MCMC plan to notify the child's health care provider when the child misses a required blood lead screening test within 30 days of the missed test.
Major Provisions
- Requires a contract between DHCS and a MCMC plan to ensure that the MCMC plan and its contracting health care providers who are responsible for the period health assessment of a child pursuant to state regulation meet the standard of care for lead-related anticipatory guidance, screening and evaluation required pursuant to state law and regulation.
- Establishes as goals of the state that:
- Every child at risk of lead exposure receives blood lead screening tests established pursuant to the existing Health and Safety Code requirement;
- Every child who is eligible for services under the Medi-Cal program receives blood lead screening tests at 12 and 24 months of age established pursuant to the current lead-related anticipatory guidance, screening and evaluation requirements in state regulation; and,
- Every child, between two and six years of age, inclusive, who is eligible for services under the Medi-Cal program, and for whom there is no record of a previous blood lead screening test, receives at least one blood lead screening test pursuant to the most recent guidelines published by the federal Centers for Disease Control and Prevention.
- Requires DHCS to annually post on its dashboard on its internet website a report detailing the DHCS' progress toward the goals above. Requires the report to include the number of Medi-Cal beneficiaries who are children in each county, broken down by the age of children who have and have not received blood lead screening.
- Requires the breakdown in 3), above, to identify children by the following age groups:
- Newborn to one year of age, inclusive;
- One year and one day to two years of age, inclusive; and,
- Two years and one day to six years of age; inclusive.
- Requires DHCS to ensure, with respect to a Medi-Cal beneficiary who is a child, and consistent with the requirements of existing state regulation on lead-related anticipatory guidance, screening and evaluation of both of the following:
- That a child receives a blood lead screening test at 12 and 24 months of age pursuant to state regulations; and,
- That a child between two and six years of age, inclusive, for whom there is no record of a previous blood lead screening test, receives at least one blood lead screening test pursuant to state regulations.
- Requires each MCMC, in order to comply with the requirements above, to do all of the following:
- Establish a monitoring system that ensures each child receives required blood lead screening tests;
- Require its contracting health care providers who are responsible for performing a period health assessment of a child pursuant to lead-related anticipatory guidance, screening and evaluation requirements in state to regulation, to test each child pursuant to state and federal law, regulations, and guidelines as indicated in DHCS' Blood Lead Test and Anticipatory Guidance.
- Requires MCMC plans to inform, at the time that a child under six years of age becomes a beneficiary under the Medi-Cal program, and annually thereafter, the child's parent, parents, guardian, or other person charged with their support and maintenance about all of the following:
- The risks and effects of lead exposure;
- The requirement for a child to receive blood lead screening tests at age appropriate intervals; and,
- The recommendation that a child receive a blood lead screening test if they are at risk of lead exposure.
- Requires the MCMC plan to notify the child's health care provider when the child misses a required blood lead screening test within 30 days of the missed test.
COMMENTS:
In January 2020, the California State Auditor (CSA) released an audit entitled "Childhood Lead Levels – Millions of Children in Medi-Cal Have Not Received Required Testing for Lead Poisoning." The CSA audit is critical of DHCS and DPH, stating that millions of children who should have been tested for elevated lead levels have not received all of the tests they should have because DHCS and DPH have failed to adequately accomplish the duties with which they have been entrusted. Related to what MCMC plans could do to improve lead screening, the CSA stated DHCS could:
- Require MCMC plans to identify children who have not received lead tests and remind their health care providers of the need to provide the tests—a method other states have successfully used to increase testing rates;
- Prioritize its effort to adopt a performance standard for lead tests and ensure that this standard is specifically designed to monitor its success in meeting the State's requirements for the lead testing of one‑ and two‑year‑old children; and,
- Incorporate into its contracts with MCMC plans a requirement that the plans identify each month all children without records of required lead tests and remind the responsible health care providers of the need to test those children.
According to the Author:
Protecting the state's most vulnerable must be a top priority for the Legislature. Studies have shown that lead exposure disproportionately impacts low income communities, and that the damage can cause cognitive disabilities and other forms of irreparable harm. This bill ensures that vulnerable children, such as those on Medi-Cal, are receiving blood lead tests by creating the necessary accountability mechanisms to ensure compliance and proper tracking of existing blood lead test mandates; a need indicated by the State Auditor.
Arguments in Support:
This bill is jointly sponsored by the Environmental Working Group and the Coalition of California Welfare Rights and Organizations, which write that lead is a severe neurotoxin that even in small doses can lower a child's IQ and cause behavior and learning disorders. All children can be exposed to lead, but DPH states that the vast majority – 88% - of California's lead-poisoned kids are enrolled in Medi-Cal. Low-income children are more apt to be lead-poisoned because they are more likely to live in older housing with lead paint, and be malnourished, which causes them to absorb lead faster. If not stopped, a child's ongoing exposure to lead will continue to harm their nervous system, and cause damage that can last a lifetime. Because lead exposure happens silently, and disproportionately affects low income kids, state and federal regulations require all Medi-Cal toddlers to receive blood lead tests when they are one and two years old. Unfortunately, many of these children are not tested as required. A recent state audit of state data found that an estimated 70% of the state's 12 and 24-month old children who are enrolled in Medi-Cal do not receive blood lead screenings each year in accordance with federal and state regulations. This finding supports several other analyses, including one published in the peer-reviewed journal Pediatrics. This analysis found that more than 63% of California's children with elevated blood lead levels above 10 mcg/dL are not identified. California must and should identify as many lead-exposed children as the law requires. At the minimum, DHCS should ensure that the established lead-testing requirement for Medi-Cal recipient children is met, and DHCS should develop a case management system that will allow the state to track these childrens' blood lead tests. In addition, parents of Medi-Cal children should be informed about the federal childhood blood lead screening requirements, as well as the risks associated with childhood lead exposure. This bill addresses these needs and will bring California many steps closer to ensuring that our most vulnerable children receive protective lead screening services and information.
Arguments in Opposition:
There is no known opposition to this bill.
FISCAL COMMENTS:
According to the Assembly Appropriations Committee:
- Ongoing administrative costs to DHCS in the hundreds of thousands of dollars annually (General Fund (GF)/federal funds).
- Significant unknown costs to prepare and mail information annually to all families with young children about blood lead screening tests (GF/federal funds).
- Unknown, significant costs associated with increased capitation (per-member, per-month) payments to MCMC plans (GF/federal funds).
VOTES:
ASM HEALTH: 15-0-0
YES: Wood, Mayes, Aguiar-Curry, Bigelow, Bonta, Burke, Carrillo, Flora, Limón, McCarty, Nazarian, Ramos, Rodriguez, Santiago, Waldron
ASM APPROPRIATIONS: 18-0-0
YES: Gonzalez, Bigelow, Bauer-Kahan, Bloom, Bonta, Calderon, Carrillo, Chau, Megan Dahle, Diep, Eggman, Fong, Gabriel, Eduardo Garcia, Petrie-Norris, McCarty, Robert Rivas, Voepel
UPDATED:
VERSION: May 12, 2020
CONSULTANT: Scott Bain / HEALTH / (916) 319-2097 FN: 0002901
Date of Hearing: June 2, 2020
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Lorena Gonzalez, Chair
ABPCA Bill Id:AB 2276
Author:(Reyes) – As Amended Ver:May 12, 2020
Policy Committee: | Health | Vote: | 15 - 0 |
Urgency: No State Mandated Local Program: No Reimbursable: No
SUMMARY:
This bill implements accountability measures related to blood lead screening for children enrolled in Medi-Cal. Specifically, this bill:
- Establishes state goals for blood lead screening tests for children and requires the Department of Health Care Services (DHCS) to annually post on its website a report detailing progress toward the goals.
- Requires a contract between DHCS and a Medi-Cal managed care (MCMC) plan to ensure that the MCMC plan and its contracting health care providers meet the standard of care for blood lead screening and evaluation required by law and regulation.
- Requires an MCMC plan to inform the parent or guardian of a child under six years of age, at the time the child becomes a beneficiary of the Medi-Cal program, and annually thereafter, about the risks and effects of lead exposure as well as requirements and recommendations related to blood lead screening tests.
- Requires an MCMC plan to notify the child’s health care provider when the child misses a required blood lead screening test, within 30 days of the missed test.
FISCAL EFFECT:
- Ongoing administrative costs to DHCS in the hundreds of thousands of dollars annually to monitor health plan compliance with contracts and progress towards goals, and to report data (GF/federal).
- Significant costs of an unknown amount to prepare and mail information annually to all families with young children about blood lead screening tests (GF/federal). According to a state audit further discussed below, DHCS is already working on a targeted outreach campaign to inform beneficiaries about the availability of a range of recommended children’s preventive health care services under Medi-Cal and how to access them. Part of this outreach will include highlighting the availability of blood lead screening tests. This bill would make such outreach efforts permanent and ongoing, for purposes of blood lead screening.
- Unknown, significant costs associated with increased capitation (per-member, per-month) payments to MCMC plans. This bill would require individual-level tracking and follow-up for each missed test. Administrative costs for each contracting plan to develop its own monitoring system to track blood lead tests for children enrolled in Medi-Cal are unknown but significant. Because capitation payments are developed based on MCMC plans’ costs to serve Medi-Cal beneficiaries, these increased administrative costs to MCMC plans would be passed on to the state through higher capitation payments. (GF/federal).
COMMENTS:
- Purpose. This bill is intended to ensure vulnerable children on Medi-Cal receive blood lead screening by creating mechanisms to ensure compliance and proper tracking of existing blood lead screening mandates. This bill is co-sponsored by Coalition of California Welfare Rights Organizations and the Environmental Working Group.
- Background. Lead is harmful to neural development of children and no level of lead in the blood is safe. Because there is no safe level of lead and no treatment for lead poisoning, two main public health strategies are employed: educating parents and caregivers about identifying and keeping children safe from lead hazards, and preventing lead poisoning through environmental remediation.
Blood lead screening alerts providers, parents and public health officials to elevated levels of blood lead, but there is unfortunately no effective treatment. The California Department of Public Health (CDPH) maintains a web-based system whereby blood lead test results are reported electronically to the department. This system has been mostly used to identify cases of high blood levels for individual case management, but CDPH and DHCS have recently begun collaborating to match Medi-Cal data with data in CDPH's system.
If a blood test shows a high blood lead level, a child is contacted by a state-contracted, locally administered case management program that includes public health nursing and environmental follow-up to detect and eliminate lead exposure pathways. The case management function is overseen by CDPH. Case management includes finding and eliminating the source of the lead, instruction in personal and household hygiene measures, optimizing the child's diet and nutritional status, and close follow-up.
Blood lead screening is one of a large number of recommended children’s preventive health services. DHCS is responsible for ensuring the delivery of these recommended services and does so largely through contracts with MCMC plans, who in turn contract with individual health care providers.
All children enrolled in publicly funded health care programs (e.g., Medi-Cal) are considered part of the target population for blood lead screening, which also includes children living in older homes. Blood lead screening is recommended for children who are at-risk and at certain ages. Current law and regulation requires providers to administer such tests.
Providers, MCMC plans, DHCS and CDPH all have either legal or contractual mandates related to blood lead screening, complicating the question of which entity is ultimately responsible to ensure screening occurs and at what level a “missed” screening test should be identified and followed up on.
- California State Audit on Childhood Lead Levels. In January 2020, the California State Auditor released an audit entitled “Childhood Lead Levels – Millions of Children in Medi-Cal Have Not Received Required Testing for Lead Poisoning.” The audit is critical of DHCS and CDPH, finding millions of children who should have been tested for elevated lead levels have not received all of the recommended tests because DHCS and CDPH have failed to adequately accomplish their respective duties. The State Auditor made a large number of recommendations to improve accountability.
According to the audit responses, a number of initiatives have already been undertaken to address the issues raised. DHCS provided the following responses to State Auditor recommendations:
- DHCS will include a Blood Lead Screening measure in the first version of its Preventive Services Utilization Report by December 2020.
- DHCS has already implemented a Value-Based Payment program whereby providers receive an incentive payment meeting certain metrics, one of which DHCS states is blood lead screening.
- DHCS is implementing a targeted outreach campaign to inform beneficiaries about the availability of recommended children’s preventive services under Medi-Cal and how to access them. Part of this outreach will include highlighting the availability of blood lead screening children in Medi-Cal are entitled to receive. It will be followed by a more targeted outreach notice to be mailed to beneficiaries who have not accessed preventive services during the prior twelve months. MCMC plans will also conduct a call campaign to follow up with families of children who have not used preventive services over the course of a year, including lead testing services for children younger than six years old.
- By June of 2020, DHCS will submit a contract amendment to the Centers for Medicare and Medicaid Services (CMS) for approval that will include a requirement for MCMC plans to identify each quarter all children with no record of receiving a required lead test and remind the responsible health care providers of the requirement to test the children. Given CMS has a contract review and approval process, DHCS will release an “All Plan Letter” establishing the policy, pending contract approval from CMS. DHCS will review heath plan policies and procedures to ensure compliance with the policy. DHCS will also review the MCMC process related to this contractual requirement during its annual medical audit, and impose a corrective action plan if non-compliance is identified. Since the DHCS annual medical audit is a one-year retrospective audit, DHCS will begin auditing this policy in July 2021.
In addition, in its response to the audit, CDPH states it has drafted the 2019 biennial report, “Update on California's Progress in Preventing and Managing Childhood Lead Exposure,” and plans to release it later this year.
- Related Legislation. AB 2060 (Holden), pending in this committee, amends the California Safe Drinking Water Act (CSDWA) to define “lead free,” for purposes of manufacturing, industrial processing, or conveying or dispensing water for human consumption, to mean not more than one microgram of lead under certain tests and meeting a specified certification when used with respect to end-use devices.
AB 2277 (Salas, Cristina Garcia, Quirk and Reyes), pending in this committee, contains provisions similar to those in this bill that establish notification when a child misses a required blood lead screening test and reminders to health care providers of the need to perform required blood lead screening tests.
AB 2278 (Quirk) addresses data matching for blood lead screening laboratory results. AB 2278 is in the Assembly Health Committee but is no longer being pursued by the author.
AB 2279 (Cristina Garcia, Quirk, Reyes and Salas), pending in this committee, adds several additional risk factors required to be considered as part of the standard of care for a lead poisoning evaluation of children and requires CDPH to update its formula for allocating lead poisoning prevention funds to local agencies.
AB 2422 (Grayson) addresses data matching for blood lead screening laboratory results and requires a public registry of lead-contaminated locations reported to CDPH pursuant to current law. AB 2422 is in the Assembly Health Committee but is no longer being pursued by the author.
AB 2488 (Gonzalez), currently in the Assembly Rules Committee, is a spot bill amending the Lead-Safe Schools Protection Act. (The Act requires CDPH to perform various activities related to reducing the risk of exposure to lead hazards in public schools.)
AB 2677 (Santiago), pending in the Environmental Safety and Toxics Materials Committee, creates in the California Environmental Protection Agency the position of community liaison, the duties of which would include community outreach and dissemination of information relating to cleanup of the lead contamination in the areas surrounding the Exide Technologies facility in the City of Vernon and coordination with the Department of Toxic Substances Control to address issues raised by residents affected by the lead contamination in the areas surrounding the Exide Technologies facility.
SB 1008 (Leyva), pending in Senate Health Committee, requires CDPH to design, implement, and maintain an online lead information registry and use registry information while protecting privacy and confidentiality of nonpublic information.
- Prior Legislation. This bill is similar to AB 2122 (Reyes), of the 2017-18 Legislative Session, which was vetoed. The veto message noted Governor Brown’s desire to allow DHCS to continue working with MCMC plans, health care providers and public health officials to determine what additional policies and practices may be necessary to improve screening rates.
- Staff Comments. It is unclear why the bill requires MCMC plans to report to DHCS information about beneficiaries receiving case management services. Case management services for children with high lead levels are provided by county staff and coordinated through CDPH, not MCMC plans. In general, to ensure efficiency and effectiveness, the bill’s approach should be more tailored to align with, enhance and strengthen DHCS’s existing efforts to respond to the state audit.
Analysis Prepared by: Lisa Murawski / APPR. / (916) 319-2081
Date of Hearing: May 18, 2020
ASSEMBLY COMMITTEE ON HEALTH
Jim Wood, Chair
ABPCA Bill Id:AB 2276
Author:(Reyes) – As Amended: Ver:May 12, 2020
SUBJECT: Medi-Cal: Blood lead screening tests.
SUMMARY: Establishes statutory state goals for blood lead screening tests for children, and requires the Department of Health Care Services (DHCS) to annually post on its internet website a report detailing its progress toward the goals. Requires a contract between DHCS and a Medi-Cal managed care (MCMC) plan to ensure that the MCMC plan and its contracting health care providers who are responsible for the period health assessment of a child pursuant to state regulation meet the standard of care for lead-related anticipatory guidance, screening and evaluation required pursuant to state law and regulation. Requires the MCMC plan to notify the child’s health care provider when the child misses a required blood lead screening test within 30 days of the missed test. Specifically, this bill:
- Requires a contract between DHCS and a MCMC plan to ensure that the MCMC plan and its contracting health care providers who are responsible for the period health assessment of a child pursuant to state regulation meet the standard of care for lead-related anticipatory guidance, screening and evaluation required pursuant to state law and regulation.
- Establishes as goals of the state that:
- Every child at risk of lead exposure receives blood lead screening tests established pursuant to the existing Health and Safety Code requirement;
- Every child who is eligible for services under the Medi-Cal program receives blood lead screening tests at 12 and 24 months of age established pursuant to the current lead-related anticipatory guidance, screening and evaluation requirements in state regulation; and,
- Every child, between two and six years of age, inclusive, who is eligible for services under the Medi-Cal program, and for whom there is no record of a previous blood lead screening test, receives at least one blood lead screening test pursuant to the most recent guidelines published by the federal Centers for Disease Control and Prevention (CDC).
- Requires DHCS to annually post on its dashboard on its internet website a report detailing the DHCS’ progress toward the goals above. Requires the report to include the number of Medi-Cal beneficiaries who are children in each county, broken down by the age of children who have and have not received blood lead screening.
- Requires the breakdown in 3) above to identify children by the following age groups:
a) Newborn to one year of age, inclusive:
b) One year and one day to two years of age, inclusive; and,
c) Two years and one day to six years of age; inclusive.
- Requires DHCS to ensure, with respect to a Medi-Cal beneficiary who is a child, and consistent with the requirements of existing state regulation on lead-related anticipatory guidance, screening and evaluation of both of the following:
- That a child receives a blood lead screening test at 12 and 24 months of age pursuant to state regulations; and,
- That a child between two and six years of age, inclusive, for whom there is no record of a previous blood lead screening test, receives at least one blood lead screening test pursuant to state regulations.
- Requires each MCMC, in order to comply with the requirements above, to do all of the following:
- Establish a monitoring system that ensures each child receives required blood lead screening tests;
- Require its contracting health care providers who are responsible for performing a period health assessment of a child pursuant to lead-related anticipatory guidance, screening and evaluation requirements in state to regulation, to test each child pursuant to state and federal law, regulations, and guidelines as indicated in DHCS’ Blood Lead Test and Anticipatory Guidance.
- Requires MCMC plans to inform, at the time that a child under six years of age becomes a beneficiary under the Medi-Cal program, and annually thereafter, the child’s parent, parents, guardian, or other person charged with their support and maintenance about all of the following:
- The risks and effects of lead exposure;
- The requirement for a child to receive blood lead screening tests at age appropriate intervals; and,
- The recommendation that a child receive a blood lead screening test if they are at risk of lead exposure.
- Requires the MCMC plan to notify the child’s health care provider when the child misses a required blood lead screening test within 30 days of the missed test.
EXISTING LAW:
- Requires the Department of Public Health (DPH), under the Childhood Lead Poisoning Prevention (CLPP) Act of 1991, to adopt regulations establishing a standard of care, at least as stringent as the most recent CDC screening guidelines, whereby all children are evaluated for risk of lead poisoning by health care providers during each child’s periodic health assessment.
- Establishes the Medi-Cal program, which is administered by DHCS and under which qualified low-income individuals receive health care services.
- Makes children age 18 and under with incomes up to 266% of the federal poverty level eligible for Medi-Cal.
- Authorizes the Director of DHCS to contract, on a bid or non-bid basis, with any qualified individual, organization, or entity to provide services to, arrange for, or case manage the care of Medi-Cal beneficiaries.
- Establishes a schedule of benefits in the Medi-Cal program, which includes the Early and Periodic Screening, Diagnostic and Treatment (EPSDT) program for any individual under 21 years of age, consistent with the requirements of a specified EPSDT provision of federal Medicaid law.
- Requires, under federal Medicaid law, EPSDT services to include screening, vision, dental, hearing and other Medicaid health care, diagnostic services, treatment, and other measures to correct or ameliorate defects and physical and mental illnesses and conditions discovered by the screening services. Includes as EPSDT services laboratory tests, including blood lead level (BLL) assessment appropriate for age and risk factors.
- Requires the governing body of each county to establish a community child health and disability prevention (CHDP) program for the purpose of providing EPSDT assessments of the health status of children in the county. Makes the CHDP program the responsibility of DHCS for all counties that contract with the state for health services.
- Requires, pursuant to state CHDP program regulation, every health care provider who performs a periodic health assessment of a child at the ages below to comply with the following standard of care:
- Provide oral or written anticipatory guidance to a parent or guardian of the child, including, at a minimum, the information that children can be harmed by exposure to lead, especially deteriorating or disturbed lead-based paint and the dust from it, and are particularly at risk of lead poisoning from the time the child begins to crawl until 72 months of age;
- If the child receives services from a publicly funded program for low-income children, order the child screened for lead poisoning as the child is presumed to be at risk of lead poisoning; and,
- If the child does not receive services from a publicly funded program for low-income children, evaluate the child's risk of lead poisoning by asking a parent or guardian of the child the following question: “Does your child live in, or spend a lot of time in, a place built before 1978 that has peeling or chipped paint or that has been recently renovated?” If the parent or guardian answers “yes” or “don't know” to the question, order the child screened for lead poisoning.
- Requires the health care provider to perform the actions above at each of the following times:
- Requires the anticipatory guidance required 8a) to be performed at each periodic health assessment, starting at six months of age and continuing until 72 months of age; and,
- Requires the screening and evaluation required by 8c) to be performed:
- When the child is 12 months of age;
- When the child is 24 months of age;
- Whenever the health care provider performing a periodic health assessment becomes aware that the child is 12 months to 24 months of age and the actions specified in 8b) and c) above were not taken at 12 months of age or thereafter;
- Whenever the health care provider performing a periodic health assessment becomes aware that the child is 24 months to 72 months of age and the actions specified in 8b) and c) above were not taken when the child was 24 months of age or thereafter; and,
- Whenever the health care provider performing a periodic health assessment of a child 12 to 72 months of age becomes aware that, in the professional judgment of the health care provider, a change in circumstances has put the child at risk of lead poisoning.
FISCAL EFFECT: This bill has not been analyzed by a fiscal committee.
COMMENTS:
- PURPOSE OF THIS BILL. According to the author, protecting the state’s most vulnerable must be a top priority for the Legislature. Studies have shown that lead exposure disproportionately impacts low income communities, and that the damage can cause cognitive disabilities and other forms of irreparable harm. This bill ensures that vulnerable children, such as those on Medi-Cal, are receiving blood lead tests by creating the necessary accountability mechanisms to ensure compliance and proper tracking of existing blood lead test mandates; a need indicated by the State Auditor.
- BACKGROUND. According to the CDC, at least four million households include children that are being exposed to high levels of lead. Children are exposed to lead from different sources (such as paint, gasoline, solder, and consumer products like candy, artificial turf, and toys) and through different pathways (such as air, food, water, dust, and soil). Although there are several exposure sources, lead-based paint is the most widespread and dangerous high-dose source of lead exposure for young children. There are approximately half a million U.S. children ages one to five years with BLLs above five micrograms per deciliter (µg/dL), a level at which CDC recommends public health actions be initiated. No safe BLL in children has been identified, and exposure can affect nearly every system in the body. Because lead exposure often occurs with no obvious symptoms, it frequently goes unrecognized. Children at higher risk for lead exposure are poor, are members of racial-ethnic minority groups, are recent immigrants, live in older, poorly maintained rental properties, or have parents who are exposed to lead at work.
- CALIFORNIA STATE AUDITOR AUDIT ON CHILDHOOD LEAD LEVELS. In January 2020, the California State Auditor (CSA) released an audit entitled “Childhood Lead Levels – Millions of Children in Medi-Cal Have Not Received Required Testing for Lead Poisoning.” The CSA audit is critical of DHCS and DPH, stating that millions of children who should have been tested for elevated lead levels have not received all of the tests they should have because DHCS and DPH have failed to adequately accomplish the duties with which they have been entrusted. The Auditor found children enrolled in Medi-Cal often have not received the medical tests needed to identify elevated lead levels even though the State mandates such testing. With limited exceptions, California requires that children enrolled in Medi-Cal receive tests for elevated lead levels at the ages of one and two years. However, according to DHCS’ data, millions of children in Medi-Cal did not receive the lead tests they should have. These data show that from fiscal years 2009–10 through 2017–18, more than 1.4 million of the 2.9 million one- and two-year old children enrolled in Medi-Cal did not receive any of the required tests and another 740,000 children missed one of the two tests. According to DHCS’ data, the rate of eligible children receiving all of the tests that they should have was less than 27%. CSA states that many of these children live in areas of the State with high occurrences of elevated lead levels, making the low testing rates even more troubling. Related to what MCMC plans could do to improve lead screening, the CSA stated DHCS could:
- Require MCMC plans to identify children who have not received lead tests and remind their health care providers of the need to provide the tests—a method other states have successfully used to increase testing rates;
- Prioritize its effort to adopt a performance standard for lead tests and ensure that this standard is specifically designed to monitor its success in meeting the State’s requirements for the lead testing of one‑ and two‑year‑old children; and,
- Incorporate into its contracts with MCMC plans a requirement that the plans identify each month all children without records of required lead tests and remind the responsible health care providers of the need to test those children.
- Percentage of Medi-Cal children up to age three receiving BLL screening. DHCS and DPH provided the Assembly Environmental Safety and Toxics Material Committee with an updated percentage of the number of children in Medi-Cal who have received a BLL screening test for an oversight hearing by that committee conducted in February 2018. BLL data collected by DHCS and DPH is very different. Medi-Cal data is based on the submittal of a claim or encounter that includes specific procedure and diagnosis codes that indicate a BLL screening has been performed. DHCS receives administrative data in the forms of claims (for fee-for-service beneficiaries) or encounter data (for MCMC plan enrollees). Such data only indicates a BLL test occurred if Medi-Cal was billed specifically for a BLL test. DHCS’ data would not indicate the completion of a BLL test if a primary care provider performed the test but only billed for an office visit. In contrast, DPH receives data on BLL tests performed at laboratories, including those in a physician’s office. DPH has limited data on who is and who is not a Medi-Cal beneficiary. When the data from DPH is added to the data from DHCS, the percentage of children 12 to 23 months old who were continuously enrolled in Medi-Cal for a year for a year and who were screened for lead was 48.8%. Among those 24 to 35 months old, the percentage of children screened was 40.5%.
- EPSDT. The purpose of EPSDT is to discover and treat childhood health conditions before they become serious or disabling. States must inform all Medicaid-eligible families about the benefit, screen children at reasonable intervals, diagnose and treat any health problems found, and report certain data regarding EPSDT participation annually to the Centers for Medicare & Medicaid Services (CMS). The EPSDT benefit is more robust than the Medi-Cal benefit package provided to adults. For example, services that are optional benefits under federal law for adults in Medi-Cal (such as dental, eyeglasses, physical and occupational therapy and pharmacy) are required goods and services under EPSDT. The EPSDT benefit is designed to ensure that eligible members receive early detection and preventive care in addition to medically necessary treatment services, so that health problems are averted or diagnosed and treated as early as possible.
- Bright Futures. The CHDP program is responsible for the screening component of the EPSDT benefit of the Medi-Cal program, including the health assessments, immunizations, and laboratory screening procedures for Medi-Cal children. The CHDP program issues guidelines for pediatric health assessments for children served by the CHDP program. DHCS indicates these guidelines are consistent with the AAP Bright Futures Guidelines and provide guidance to ensure compliance with California state specific regulations, and that all CHDP program providers are required to comply with the most recent AAP Bright Futures Guidelines and the AAP Bright Futures Recommendations for Preventive Pediatric Health Care. The Bright Futures guidelines recommend screening for lead at six months, nine months, 12 months, 24 months, and at three years of age.
MCMC plans are required to cover and ensure the provision of screening, preventive, and medically necessary diagnostic and treatment services for individuals under the age of 21 (including specified EPSDT services). As part of the model contract between DHCS and MCMC plans, plans are required to cover and ensure the provision of a blood lead screening test to children at ages one and two in accordance with existing CHDP program regulations, and to document and appropriately follow up on blood lead screening test results. Plans are also required to make reasonable attempts to ensure the blood lead screen test is provided and to document attempts to provide the test in the child’s medical record. Documentation is required to be entered in to the child’s medical record to indicate the receipt of blood lead screen testing and test results, of voluntary refusal of these services, or of nonresponse.
- DHCS Guidance on Blood Lead Screening of Young Children. In October 2018, DHCS released an All Plan Letter (APL) to MCMC plans regarding blood lead screening of young children to clarify blood lead screening and reporting requirements for MCMC plans. DHCS stated federal law requires states to screen children enrolled in Medicaid for elevated blood lead levels as part of required prevention services offered through EPSDT. Accordingly, CMS released an informational bulletin in November 2016 that provides an overview of blood lead screening requirements for children enrolled in Medicaid.
In addition, DHCS stated MCMC plans are required under their contracts with DHCS to cover and ensure the provision of blood lead screenings in accordance with California state regulations. These regulations impose specific responsibilities on doctors, nurse practitioners, and physician assistants conducting periodic health care assessments on children between the ages of six months and six years. MCMC plans must ensure that their contracted providers (physicians, nurse practitioners, and physician’s assistants), who perform periodic health assessments on children between the ages of six months to six years, comply with current federal and state laws and industry guidelines for health care providers issued by CLPPB, including any future updates or amendments. DHCS currently utilizes encounter data for tracking the administration of blood lead screenings. MCMC plans must ensure that blood lead screening encounters are identified using the appropriate indicators (such as Current Procedural Terminology codes). MCMC plans are required to have written policies and procedures describing methods of ensuring and monitoring provider compliance with the requirements detailed in the APL. MCMC plans are responsible for ensuring that their delegates and subcontractors comply with all applicable state and federal laws and regulations, contract requirements, and other DHCS guidance, including APLs. These requirements must be communicated by each MCMC plan to all delegated entities and subcontractors. - SUPPORT. This bill is jointly sponsored by the Environmental Working Group and the Coalition of California Welfare Rights and Organizations, which write that lead is a severe neurotoxin that even in small doses can lower a child’s IQ and cause behavior and learning disorders. All children can be exposed to lead, but DPH states that the vast majority -- 88% -- of California’s lead-poisoned kids are enrolled in Medi-Cal. Low-income children are more apt to be lead-poisoned because they are more likely to live in older housing with lead paint, and be malnourished, which causes them to absorb lead faster. If not stopped, a child’s ongoing exposure to lead will continue to harm their nervous system, and cause damage that can last a lifetime. Because lead exposure happens silently, and disproportionately affects low income kids, state and federal regulations require all Medi-Cal toddlers to receive blood lead tests when they are one and two years old. Unfortunately, many of these children are not tested as required. A recent state audit of state data found that an estimated 70% of the state’s 12 and 24-month old children who are enrolled in Medi-Cal do not receive blood lead screenings each year in accordance with federal and state regulations. This finding supports several other analyses, including one published in the peer-reviewed journal Pediatrics. This analysis found that more than 63% of California’s children with elevated blood lead levels above 10 mcg/dL are not identified. California must and should identify as many lead-exposed children as the law requires. At the minimum, DHCS should ensure that the established lead-testing requirement for Medi-Cal recipient children is met, and DHCS should develop a case management system that will allow the state to track these childrens’ blood lead tests. In addition, parents of Medi-Cal children should be informed about the federal childhood blood lead screening requirements, as well as the risks associated with childhood lead exposure. This bill addresses these needs and will bring California many steps closer to ensuring that our most vulnerable children receive protective lead screening services and information.
- RELATED LEGISLATION. AB 2060 (Holden) would amend the California Safe Drinking Water Act (CSDWA) to define “lead free,” for purposes of manufacturing, industrial processing, or conveying or dispensing water for human consumption, to mean not more than one microgram of lead under certain tests and meeting a specified certification when used with respect to end-use devices. The CSDWA requires the State Water Resources Control Board to administer provisions relating to the regulation of drinking water to protect public health, and the CSDWA prohibits, with certain exceptions, the use of any pipe, pipe or plumbing fitting or fixture, solder, or flux that is not lead free in the installation or repair of any public water system or any plumbing in a facility providing water for human consumption. The CSDWA currently defines “lead free” for purposes of manufacturing, industrial processing, or conveying or dispensing water for human consumption to mean not more than 0.2% lead when used with respect to solder and flux and not more than a weighted average of 0.25% lead when used with respect to the wetted surfaces of pipes and pipe fittings, plumbing fittings, and fixtures. AB 2060 is awaiting hearing in the Assembly Appropriations Committee.
AB 2277 (Salas, Cristina Garcia, Quirk, and Reyes) requires DHCS to notify the parent or guardians charged with the support of a child who enrolled in Medi-Cal when that child misses a required blood lead screening test. Requires a contract between DHCS and a MCMC plan to impose on the plan, the requirement to identify every enrollee who is a child without any record of completing required blood lead screening tests on a monthly basis, and to remind the responsible health care provider of the need to perform required blood lead screening tests. AB 2277 is scheduled for hearing in the Assembly Health Committee on May 18, 2020.
AB 2278 (Quirk) requires an analyzing laboratory that performs a blood lead analysis to also report to DPH the person’s telephone number in addition to the person’s address and ZIP code if the analyzing laboratory has that information, and the Medi-Cal identification number and medical plan identification number, if available. Requires the existing “within 30 calendar day” timeframe for an analyzing laboratory to report less to DPH a blood lead test of less than 10 micrograms per deciliter begins from the date of the analysis. AB 2278 is in the Assembly Health Committee but is no longer being pursued by the author.
AB 2279 (Cristina Garcia, Quirk, Reyes, and Salas) add several additional risk factors required to be considered as part of the standard of care for a lead poisoning evaluation of children required to be established by DPH in regulation, such as a child’s residency in or visit to a foreign country, their residency in a high-risk ZIP Code, a child’s proximity to current or former lead-producing facilities. Requires DPH to develop, by January 1, 2021, the regulations on the additional risk factors, in consultation with the specified individuals in existing law. Requires DPH to update its formula for allocating funds to any local agency that contracts with DPH to administer the Childhood Lead Poisoning Prevention Program (CLPPP), and to revise funding allocations before each contract cycle. AB 2279 is scheduled for hearing in the Assembly Health Committee on May 18, 2020.
AB 2422 (Grayson) would add to the information that a laboratory is required to report to DPH when it performs a blood lead analysis test to include the Medi-Cal identification number, or other equivalent medical identification number of the person tested. Requires, if the person tested is a minor, that the laboratory include the person’s contact information and a unique identifier, in a form to be determined by DHCS, as specified. Requires DPH to develop and maintain on its internet website a public registry of lead-contaminated locations reported to DPH pursuant to the provisions relating to lead hazards in buildings. Requires DPH to ensure that personally identifiable information, including medical information, is not disclosed or ascertainable from the information available on the registry. AB 2422 is in the Assembly Health Committee but is no longer being pursued by the author.
AB 2488 (Gonzalez) is a spot bill amending the Lead-Safe Schools Protection Act (the Act requires the DPH to perform various activities related to reducing the risk of exposure to lead hazards in public schools, as defined, including, among other activities, conducting a sample survey to determine the likely extent and distribution of lead exposure to children from paint on the school, soil in play areas at the school, drinking water at the tap, and other potential sources identified by DPH for this purpose, as provided). AB 2488 is in the Assembly Rules Committee.
AB 2677 (Santiago) would create in the California Environmental Protection Agency, under the direction of the Secretary for Environmental Protection, the position of community liaison, the duties of which would include, but are not limited to, community outreach and dissemination of information relating to cleanup of the lead contamination in the areas surrounding the Exide Technologies facility in the City of Vernon and coordination with the Department of Toxic Substances Control to address issues raised by residents affected by the lead contamination in the areas surrounding the Exide Technologies facility. AB 2677 is awaiting hearing in the Environmental Safety and Toxics Materials Committee.
SB 1008 (Leyva) would require DPH to: a) design, implement, and maintain an online lead information registry on its internet website that enables the public to determine the lead inspection and abatement status for properties; and, b) use information it maintains for the registry to the extent that DPH ensures that any personally identifying information, including medical information, is made unavailable to the public. SB 1008 is awaiting hearing in the Senate Health Committee.
- PREVIOUS LEGISLATION. AB 2122 (Reyes) of 2018 would have: a) established requirements DHCS and MCMC care plans to ensure children receive blood lead screening, information about lead exposure and testing, and follow-up services for children with an elevated blood lead level, including a contractual requirement for plans and their contractors to meet the standard of care for lead testing; b) establishes state goals for children at risk of lead exposure and for blood testing for children under age who are eligible for Medi-Cal; c) requires DHCS to include blood lead screening tests as a plan performance measure in its annual External Accountability Set, and requires DHCS to annually create a report detailing the DHCS’ progress toward the state goals; and, d) require DPH to prepare provider training guidelines, curriculum, and resources that are required to be used to educate providers about childhood lead poisoning prevention, childhood lead exposure risks, childhood lead exposure health effects, and sources of childhood lead exposure at the state, regional, and local levels.
AB 2122 was vetoed by Governor Brown, who stated that “lead exposure in children is a serious health concern and I share the author's desire to increase the number of Medi-Cal children who are screened. The department, however, already requires in its contracts with managed care plans and providers that children receive screenings in accordance with federal and state regulations. Updated and more thorough data on periodic screening tests is being developed with DPH to assist in tracking compliance. I believe the department should continue its current efforts working with managed care plans, health care providers and public health officials to determine what additional policies and practices may be necessary to improve screening rates.
SB 1097 (Hueso), Chapter 691, Statutes of 2018, requires DPH’s report regarding the effectiveness of appropriate lead poisoning case management efforts to include additional data and information, as specified
AB 2976 (Quirk) would have required DPH to coordinate with the state entities, including DHCS, that are responsible for administering specified publicly funded programs to gather data to determine whether children are being screened for lead poisoning, as required pursuant to existing regulation. AB 2976 was held on the Senate Appropriations Committee suspense file.
SB 775 (Ridley-Thomas) of 2007 would have, among other provisions, required DPH to make available on its Web site the most current information on lead, as specified, and would have required providers primarily responsible for providing prenatal care to explain to pregnant women that lead poisoning prevention information is available on the Web site or provide other information about lead poisoning prevention. SB 775 was vetoed by the Governor who indicated: “While I support programs to reduce lead exposure for children, this bill is duplicative of existing state requirements and may jeopardize overall funding for lead poisoning prevention. Many of the bill's provisions are unnecessary and are already being accomplished administratively.”
AB 247 (Garcia) of 2017 would have established a Statewide Lead Advisory Taskforce to review and provide recommendations regarding policies and procedures to reduce lead poisoning in the state. AB 247 was vetoed by the Governor who indicated: “The responsibilities of this task force would be duplicative of ongoing work by the Office of Environmental Health Hazard Assessment, DPH, the State Water Resources Control Board, and the Department of Toxic Substances Control. Coordination and evaluation of procedures to reduce childhood lead poisoning is being accomplished administratively amongst these agencies so there is no reason to divert resources to a task force.”
AB 1316 (Quirk), Chapter 507, Statutes of 2017, requires DPH to revise its regulations for the CLPPP to redefine the assessment of risks for the purposes of evaluating a child's risk for lead exposure.
REGISTERED SUPPORT / OPPOSITION:
Support
Coalition of California Welfare Rights Organizations (cosponsor)
Environmental Working Group (cosponsor)
American Academy of Pediatrics, California
Association of Regional Center Agencies
California Coalition of California Welfare Rights Advocates
California League of Conservation Voters
California Pan-Ethnic Health Network
CalPIRG
Children Now
Clean Water Action
Coalition of California Welfare Rights Organizations
Environmental Health Coalition
Friends Committee on Legislation of California
Healthy Black Families
National Association of Social Workers, California Chapter
National Resources Defense Council
Sierra Club California
Smart Oakland
Western Center on Law & Poverty, Inc.
Opposition
None on file.
Analysis Prepared by: Scott Bain / HEALTH / (916) 319-2097
Bill Author
Bill Co-Author(s):